Podcasts about health sdoh

Hosts Gregg Masters and Fred Goldstein meet Pravin Pant, MSHI, VP, Advanced Analytics at ZeOmega. They discuss the role and application of AI to Social Determinants of Health (SDoH), including how AI impacts care management and the patient experience. Pravin leads ZeOmega's advanced analytics team in working on new and existing AI solutions and social determinants of health (SDOH) solutions. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Steve Heard, Chief Innovation Officer at J2 Interactive, presents a strategy in this interview for dealing with new forms of data known as Social Determinants of Health (SDoH) and how traditional HIEs can evolve to help organizations exploit this data.Heard points out that SDoH has the strongest impacts on people who are poor, isolated, or otherwise marginalized, but that those populations have impacts on the health of everybody else. He therefore urges policy-makers not to "abandon" these people or ignore the needs indicated by the data.Learn more about J2 Interactive: https://www.j2interactive.com/Health IT Community: https://www.healthcareittoday.com/

Access to quality healthcare shouldn't depend on your zip code, yet for many underserved communities, barriers remain.In this episode of Straight Out of Health IT, Christopher Kunney interviewed Christopher Cruttenden, CEO of Safety Net Connect (SNC), a company providing digital healthcare tools like eConsult to improve access to specialty care for underserved populations. SNC connects medical, behavioral, and social service providers to enhance equitable healthcare access. Cruttenden highlighted major challenges in providing equitable care, including medical and food deserts, time constraints for working families, and long wait times. He emphasized the burden on patients, especially those with chronic illnesses and other socioeconomic challenges.Regarding technology's role, Cruttenden advocated for collaborative, patient-centered solutions integrated into healthcare workflows. He noted the importance of AI in supporting physicians, particularly through AI-assisted dictation, coding support, and quality assurance to enhance efficiency. By improving access to care, reducing ER visits, and enabling timely interventions through tools like eConsult, the cascading effect leads to better patient outcomes and system-wide savings. Cruttenden also discussed the concept of Return on Value (ROV) over traditional ROI in public health.eConsult operates in regions like LA County, Colorado, and through partnerships with other providers. It facilitates remote consultations, allowing specialists to provide timely input, reducing wait times and preventing unnecessary specialist visits. Cruttenden expressed excitement about expanding the model to address Social Determinants of Health (SDOH) issues, such as smoking cessation and food insecurity. His advice for public health organizations is to embrace technology thoughtfully, focusing on its ability to improve access and patient outcomes rather than just its capabilities.Tune in to explore how innovative digital tools are transforming healthcare access and improving outcomes for those who need it most! 

Lisa Welborn, Director of Media at Civilian, has over 15 years of expertise in crafting data-driven media plans that effectively reach and influence target audiences in the unique places and spaces they frequent. Lisa led the media planning and placement for the Live Beyondcampaign, winning Media Planner of The Year. Her strategic approach, particularly in understanding the unique Social Determinants of Health (SDOH) that define impacted and traditionally underserved communities, has been instrumental in delivering impactful campaigns aimed at reaching youth and driving public health awareness. Lisa's media expertise spans across traditional and digital platforms, ensuring that each campaign not only meets its objectives but also fosters long-lasting engagement and positive change. Under Lisa's leadership, the campaign which partnered with Twitch and The Drew League also delivered 58 million bonus impressions, valued at $2.477 million, through partnerships with Native American newspapers, Univision, and iHeart Media's “Conversations in Cars” program.

In this mini-series, we explore different health professions to get a better understanding of the variety of team members involved in patient care. For this episode, we chatted with social worker Lauren Judd about her journey and the essential services social workers provide to patients. Lauren Judd is a dedicated and experienced social worker with over 12 years of practice in the healthcare setting. Lauren obtained her Masters of Social Work from the University of IL at Chicago and holds a Bachelor's degree in Political Science and Germanic Language and Literature from the University of Massachusetts Amherst.  She has worked since 2015 in the Emergency Department at Loyola University Medical Center providing advocacy and support to patients, families, and medical staff.  Lauren is a member of the American Association for Emergency Psychiatry and has worked as an expert witness. Passionate about self determination and patient rights, Lauren has found empowering those experiencing mental health crises as part of an interdisciplinary team fulfilling. When not in the ED, Lauren enjoys container gardening and offbeat road trips with family and friends.  For more information, please visit the following resources: National Association of Social Workers Types of Social Work Degrees Society for Social Work Leadership in Healthcare The Center for Case Management | Leading the Industry in Case Management Consulting American Case Management Association CDC Social Determinants of Health (SDOH)  CMS Social Drivers of Health and Health-Related Social Needs  Treating the Whole Person: Vince's Story | CMS Episode produced by: Rasa Valiauga and Angeli Mittal Episode recording date: 11/4/24 www.medicuspodcast.com | medicuspodcast@gmail.com | Donate: http://bit.ly/MedicusDonate

Join us to learn more about how Highmark Health is improving community health by tackling food insecurity with Nebeyou Abebe.  Nebeyou Abebe is the Senior Vice President of Social Determinants of Health (SDoH) at Highmark Health, a $27 billion national health organization. With nearly 20 years of experience in SDoH, population health, and employee wellness, he leads initiatives to address non-clinical factors impacting health, such as housing, food insecurity, and transportation. Highmark Health, based in Pittsburgh, serves millions through its affiliated businesses and focuses on improving health outcomes by tackling both medical and non-medical drivers of poor health. Previously, Abebe was the Global Vice President of Health and Well-being at Sodexo Group, where he led efforts impacting over 100 million consumers and 425,000 employees. He also worked on public health initiatives with the Louisiana Public Health Institute and directed national campaigns for the CDC to reduce HIV/AIDS stigma. Abebe holds a bachelor's in economics from the University of Massachusetts-Amherst, a Master's in social and public policy from Georgetown University, Sponsor: The podcast is made possible by FoodNiche-ED, a gamified platform that enhances the knowledge of food and health. Learn more on foodniche-ed.com Twitter: https://twitter.com/foodniche_ed Instagram: https://www.instagram.com/foodniche_ed/ Facebook: https://www.facebook.com/FoodNicheEd/ LinkedIn:https://www.linkedin.com/company/foodniche-education About Dr. Olayanju: Dr. Julia Olayanju is a scientist and educator who advocates for enhanced nutrition education in schools and communities. She is the founder of FoodNiche-ED and FoodNiche where she and her team are driving a healthier future through programming, resources and technology.

Banner|Aetna, Blue Shield of California, Healthfirst and TytoCare explore innovative strategies that health plans can leverage to drive meaningful lifestyle modifications among members, improve health outcomes and reduce the rising costs of chronic disease.    Our expert panel also discusses the role of primary care in empowering members to adopt healthier behaviors.   Topics include: Building a culture that fosters habit formation for long-term success Supporting members using GLP-1s for weight management Addressing Social Determinants of Health (SDOH) to improve outcomes Leveraging technology to encourage sustainable lifestyle modifications   Panelists: Joe Brennan, Vice President, TytoCare Robert Groves, MD, Executive Vice President and Chief Medical Officer, Banner|Aetna Eric Glazer, Host (moderator) Angie Kalousek, Senior Director, Lifestyle Medicine, Blue Shield of California Amanda Parsons, MD, MBA, Vice President, Clinical Management, Healthfirst Bios: https://www.brightspotsinhealthcare.com/events/innovations-in-lifestyle-change-the-role-of-primary-care-2/   This episode is sponsored by TytoCare   TytoCare is a virtual healthcare company that enables leading health plans and providers to deliver remote healthcare to the whole family through its Home Smart Clinic. Combining a cutting-edge, easy-to-use, FDA-cleared device with AI-powered guidance and diagnostic support, the Home Smart Clinic enables the whole family to conduct remote physical exams with a doctor, replicating in-clinic exams for immediate answers from home. TytoCare drives utilization rates that are six times higher than traditional telehealth services; reduces the total cost of care by an average of five percent; diverts ED visits by an average of 10.8%; and has a high average NPS of 83. The Home Smart Clinic includes Tyto Engagement Labs™, a proven framework of engagement journeys designed for the successful deployment and adoption of the solution. To complete its offering, TytoCare also provides the Pro Smart Clinic, for professional settings outside the home to serve rural clinics, schools, workplaces, and more. TytoCare serves over 250 major health systems and health plans in the U.S., Europe, Asia, Latin America, and the Middle East. For more information, visit us at tytocare.com.

In this episode, Dr. Valentin Fuster reviews a pivotal document on Social Determinants of Health (SDOH) in cardiology, highlighting their critical role in shaping health outcomes. He outlines ten key insights, emphasizing the need for standardized definitions and integration of SDOH into electronic health records to promote equitable healthcare and improve patient outcomes.

Send us a textIn this episode of the Aging Well Podcast, host Dr. Jeff Armstrong is joined by Dr. Dan Dowhower to discuss the critical role of Social Determinants of Health (SDOH) in aging well. Dr. Dowhower explains what SDOH are and why they are essential, highlights key topics from his courses, and shares how these determinants specifically affect older adults. The conversation also covers significant health disparities, the importance of social support networks, effective policies, and community programs in Oregon. Dr. Dowhower offers valuable advice on advocating for better policies and taking proactive steps to mitigate negative social determinants. Tune in to learn more about improving health equity and promoting well-being for all age groups.  TruDiagnostic epigenetic testingGet a 12% discount using promo code (AGEWELL) and track your pace of aging well.Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showHave questions you want answered and topics you want discussed on the Aging Well Podcast? Send us an email at agingwell.podcast@gmail.com or record your question for us to use in an upcoming episode:https://www.speakpipe.com/AgingWellPodcast

Genetic conditions, inherited personality traits, brain chemistry...these are but a few of the well-known biological determinants of health and are but a small sample of factors that can determine how severe disease may affect a patient. But what role can social factors play in determining a patient's health? What of the ‘Social Determinants of Health (SDoH)'? Dr. Shivani Garg set out to identify these factors and understand how they play a role in determining the severity of symptoms in those with Lupus Nephritis (LN). What she discovered was that not only do these factors play a significant role, but each one added has a multiplicative effect on the patient's reported outcome! Dr. Garg is our guest today and her study, published in Arthritis Care & Rheumatology titled: Multiplicative Impact of Adverse Social Determinants of Health on Outcomes in Lupus Nephritis: A Meta-analysis and Systematic Review, will be the focus of our discussion. 

Join Corey Dion Lewis in this insightful episode of The Healthy Project Podcast as he talks with Dr. Sandra E. Ford, the former special assistant to the President for public health and science in the White House Domestic Policy Council. She is also the principal author of the White House Action Plan identifying whole-of-government policy actions to address SDoH. This episode dives into the US playbook to address SDoH, offering valuable insights into policies and practices aimed at promoting health equity. Don't miss this essential conversation on transforming health equity and improving public health outcomes. 

We know that social determinants of health such as housing instability, food insecurity, transportation barriers and limited access to education significantly influence individuals' health outcomes. By screening for these factors, healthcare providers can provide, or healthcare providers can gain a more comprehensive understanding of patients' lives beyond their medical conditions. This holistic approach allows for tailored interventions that address the root causes of health disparities. Heather Blonsky, Lead Data Scientist at Vizient, joins host Margaret Rudisill to talk about this topic and how we have used our Vizient vulnerability index tool, lovingly called the VVI tool, to address some of the nonclinical issues of each organization's top 2% in patient utilizers in our current collaborative, creating capacity transitioning of high-risk patients.   Guests: Heather Blonsky Lead Data Scientist Vizient Moderator: Margaret Rudisill PI Program Director Vizient   Show Notes: [01:27 – 04:04]  Why and how the Vizient Vulnerability Index tool was created [04:05 – 06:09]  Homelessness and how it impacts health? [06:10 – 10:02]  Other factors that are common in the top 2% utilizers and utilization of Z codes [10:03 – 11:39]  How hospitals use that and Heather's advice [11:40 – 14:05]  What do hospitals do when you they identify these needs [14:06 – 15:06]  How Vizient attempts to tie those 2% needs with the VVI and how beneficial it might be   Links | Resources: For more information, email picollaboratives@vizientinc.com   Subscribe Today! Apple Podcasts Spotify Google Podcasts Android RSS Feed

Cohosts Brent McKune and Stephen Williams of the Kentucky REC proudly introduce Episode 11 of Kentucky REC's PILL Podcast. In this episode, they sit down with KY State HIT Director and KHIE Deputy Executive Director, Andrew Bledsoe, to delve into the significance of Social Determinants of Health (SDoH) in healthcare and the state of Kentucky's efforts to address them. Learn more about KHIE at their website, KHIE.ky.gov.Episode Highlights:Unpacking the vital concept of SDoH and their pivotal role in healthcare.Gaining insights into Kentucky's unique SDoH challenges and the proactive measures taken to tackle them.Exploring the integration of kynect resources with KHIE and its advantages for healthcare organizations.Understanding the challenges that KHIE faces and its vision for the future

In this episode of BackTable ENT, pediatric otolaryngologists Dr. Anthony Sheyn (St. Jude Children's Hospital & Le Bonheur Children's Hospital), Dr. Jeffrey Rastatter (Lurie Children's Hospital of Chicago), and Dr. Daniel Chelius (Texas Children's Hospital), discuss challenges and research in health equity in pediatric head and neck cancer care. --- SHOW NOTES First, the surgeons define the Social Determinants of Health (SDoH) and explain how studying these factors improves care. They share memories of when they first reckoned with health inequities as clinicians. For Dr. Chelius, this was during medical school, when he observed end-stage renal disease patients' access to dialysis (and thus lifespan) depended on their insurance status, income, and education. Moving into his residency, he realized that similar forces shaped how patients accessed cancer care. As a young attending, Dr. Sheyn noticed that many of his patients missed appointments for logistical or financial reasons, which piqued his interest in characterizing how SDoH influence pediatric cancer care. Next, the doctors discuss health equity research. Though they're based at different institutions, the three surgeons collaborate to study how SDoH affect pediatric head and neck cancer outcomes. Dr. Rastatter shares his work identifying how different SDoH– including socioeconomic status, household composition, housing/transportation, and minority/language status – interact to affect access to cancer care. Dr. Chelius speaks to the importance of social work, advanced practice providers, and transportation services in connecting patients to care. The podcast concludes with a discussion of how tertiary care centers can better collaborate with community clinicians to ensure pediatric patients with rare cancers get the workup and treatment they need.

In this episode, Lo leads the conversation of Social Determinants of Health (SDOH). She defines SDOH and how there are health inequities in rural and minority communities. Music by J.Merritt; IG: @beatsbyjmerrittShirts  by Ebony Green; IG: @slpcontractsqueenKeith Prather Legal/ID Shield Sr. Associ Legal Shield protects and empowers you, your family, and your business by making smart full-servicDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.

Episode 38: Using AI, Data, and Telepharmacy To Drive Medication Optimization with Jason Rose, CEO of AdhereHealthWhat you'll get out of this episodeJoin host Tim Fitzpatrick as he chats with Jason Rose, CEO of AdhereHealth. In this voyage we learn more about AdhereHealth's mission to deliver data-driven technology that improves medication optimization and quality measures to achieve value-based outcomes. We also hear how Jason's 30 years of experience in this space shaped the company's rebrand and transformation since he took over its helm in 2018. Today, AdhereHealth is the market leader using telepharmacy to overcome social determinants of health (SDOH) and improve the patient experience.Disclaimer: In this video Jason incorrectly states Dr. John Halamka left Beth Israel and is now at Johns Hopkins but he is actually at Mayo Clinic.In this episode you'll discover: How AdhereHealth delivers purpose-built, innovative technology solutions to improve the quality of care, medication adherence , and cost outcomes. Why AdhereHealth is still the only national telepharmacy solution operating at scale in the United States today, touching more than 30 million people through its technologies and at-risk engagement services. How their unique combination of analytics, clinical workflow software, and proactive telepharmacy outreach addresses an estimated half a trillion dollars of unnecessary annual medical costs attributed to medication adherence issues. Why AdhereHealth developed the first-of-its-kind PRM (patient relationship management) software to further their understanding of patients' Social Determinants of Health (SDoH). How Jason and his team think about things like risk and data architecture for their PRM platform by leveraging claims data (mile wide), medical history (mile deep), and pharmacy records (updated daily). Final Frontier - 5 Questions in 50 Seconds Top Challenge: Leveraging a combination of technology and clinician enablement that actually accelerates outcomes (hint -  not an EHR) Top Opportunity:  Medication adherence Tech Trend You're Following: Public-Private Partnerships Top Media Recs:   Breaking the Habit of Being Yourself: How to Lose Your Mind and Create a New One by Dispenza, Joe.  Modern Healthcare, Fierce Healthcare, Rama on Healthcare, WSJ Rockefeller, George Lukas Healthcare / Tech Leader(s) You're Following: Elon Musk Dr. John Halamka, CIO at Mayo Clinic Dr. David Brailer, First US Health IT Czar, Bush Administration Sarah London, CEO of Centene Corporation Dan Mendelson, CEO of Morgan Health David Cordani, CEO of Cigna Gail Boudreaux, CEO of Elevance Quotables“The pandemic was a…wasted opportunity to tackle [medication adherence] in a really big way. Who were those most hurt in the pandemic? It was not about the genetic code, it was about the zip code. It was the same patients before we still see today who are not getting their drugs for the chronic conditions.”“We're using the data of yesterday to inform our decisions today, and artificial intelligence to drive our actions tomorrow.”Recommended Resources Medication Adherence Is a “Force Multiplier” for Medicare Advantage Profitability, Enrollment, Star Ratings (AJMC, 2023) The Quintuple Aim for Health Care Improvement: A New Imperative to Advance Health Equity - PubMed (nih.gov) Cost of Prescription Drug-Related Morbidity and Mortality - PubMed (nih.gov) Charting a New Path to At-Home Medication Adherence With Digital Pharmacy Support (AJMC, 2022) Join the Conversation Are you a healthcare innovator? Tell us what topics and people you'd like us to cover in future episodes:Jason Rose on LinkedInAdhereHealth on LinkedInAdhereHealth on Twitter““It's a long-standing belief that star ratings are Darwinism in healthcare. If you don't get the four stars, you've lost a percentage of your premium and lost funding to put into the product, and now because you've lost that, you've also lost membership enrollment,” says Rose. “And because you've lost the ability to compete with your peers, it's going to take two years to come back with a higher star rating.” Great article Patient Safety & Quality Healthcare and Matt Phillion!#healthcare #sdoh #pharmacy #quality #starratings#medicationadherence” @Jason Rose on LinkedInAbout Your HostTim Fitzpatrick is the CEO of IKONA Health, a company using neurobiology and immersive technology to improve how patients learn about their care and treatment options. Tim co-founded IKONA based on his own patient experiences while serving in the US Navy and now in the VA health system. He has served as Principal Investigator on multiple federal research grants, has co-authored papers on learning science, VR, and mental health in the age of COVID-19, and has partnered with top healthcare investors and institutions including the National Science Foundation, Department of Defense, National Artificial Intelligence Institute, StartUp Health, On Deck, FundRx, MATTER and NVIDIA.

To integrate the third type of data, Health Gorilla joined forces with LexisNexis® Risk Solutions. Access to such data helps clinicians identify where a patient might be more likely to make a visit or pick up medication if the clinic provides transportation. They can look at other items in what LexisNexis Risk Solutions calls a “motivation risk score.” Diana Zuskov, AVP, healthcare strategy at LexisNexis Risk Solutions, says, “When you combine quality data with the right platform it can help make the data even more actionable by various healthcare stakeholders. It's important to remember that data is the foundation in which everything else builds from and having a solid base is imperative. With thousands of data points that can be applied to each individual, analytics are required to turn up what's useful. Historically, we never thought much about what happened before the patient came into the office or what happens after they go home.” The goal of this partnership is to supplement longitudinal health assessments with “longitudinal social care.” Watch the video for more insights on the role of the community, examples of SDoH in action, and other aspects of SDoH. Learn more about Health Gorilla: https://www.healthgorilla.com/ Learn more about LexisNexis Risk Solutions: https://risk.lexisnexis.com/ Find more great health IT content: https://www.healthcareittoday.com/ LexisNexis Risk solutions is a Healthcare Scene sponsor.

In value-based care, we have both an economic and a moral imperative.  What's at stake is so much more than saving our healthcare system. It is about ensuring the continued prosperity of our nation to ensure that we leave it better for future generations. The best indicator of whether our country is on the right path is the assurance that healthy mothers can give birth to healthy children. And those children, in turn, must be assured of good care and a sound education that will enable them to face the challenges of a changing world. If we could have but one generation of properly born, educated, and healthy children, many of the insurmountable problems in our country would vanish in our lifetimes. This week on the Race to Value, you are going to hear from a value-based care leader who is boldly moving beyond with a call to action to serve our nation's youth. Karen Wilding, the Chief Value Officer at Nemours, is on a passionate pursuit of the Quadruple Aim, and her health system is redefining children's health in our country. Nemours Children's Health is truly “leaning in” to the promise of population health by transforming the very definition of what it means for children to be healthy. And their value journey reflects a bold vision to create the healthiest generations of children that will take us beyond medicine by ultimately impacting the world. If you are looking for an example of inspirational leadership in value-based care, look no further than Karen Wilding and the Nemours Children's Health System!   Episode Bookmarks: 01:30 “If we could have but one generation of properly born, educated, and healthy children, many of the insurmountable problems in our country would vanish in our lifetimes.” 02:30 Introduction to Karen Wilding, the Chief Value Officer at Nemours Children's Health 03:00 Support Race to  Value by subscribing to our weekly newsletter and leaving a review/rating on Apple Podcasts. 05:45 Karen describes the whole-person care orientation at Nemours and how the mission of “Well Beyond Medicine” guides their value-based care journey. 06:45 Social Determinants of Health (SDOH) screening in underserved populations to expand care network and create community partnerships. 07:45 Driving “macro-system impact” as an anchor institution (e.g. best practice clinical research, cross-sector partnerships, health equity investments) 08:30 Health Equity opportunities in pediatric whole-person care (e.g. teen birth rates, preventative care access, infant mortality rates…and even household income). 09:00 “Well Beyond Medicine is a commitment to not just care for the medical aspects of children – we also care for the larger health ecosystem to create whole-child health and healthier generations.” 11:45 “Payment transformation is foundational to being able to create sustainability in value-based care.” 12:30 Karen explains how the fee-for-service infrastructure does not align incentives for healthy outcomes (e.g. asthma exacerbations with children in Delaware). 13:30 “Investing in children's health is the single most important thing we can do as a society.” (balancing present-day economics vs. future economics). 14:45 Partnering with payers to pursue health equity transformation and the importance of community-based investments. 16:45 Nemours has been utilizing Community Health Workers to conduct SDOH screenings and individualized interventions through a culturally competent care model. 17:45 Karen explains how the interdisciplinary care team at Nemours works together to capture, assess, and address SDOH barriers. 18:45 The importance of enterprise-level buy-in when launching a SDOH population health strategy. 20:30 Overcoming fears and concerns of families in sharing personal information about their social barriers. 21:00 The creation of a national toolkit on whole-child population health and how Nemours is collaborating with policy stakeholders at the federal level.

Guest: Erin Gravino Jeffords, OTR/L, MS, PAMCO, CBIS - Erin Jeffords, Assistant Professor of Occupational Therapy with Lenoir-Rhyne University, discusses the impact of Social Determinants of Health (SDOH) and how it impacts patient's access to care. Geographical location, access to reliable transportation, access to reliable forms of communication, and even access to affordable internet can all impact our ability to provide services, our patient's ability to find services, and/or our patient's ability to follow through with the recommendations for intervention that we deliver. Join Erin and Michelle for an hour of hope and support for discovering and overcoming SDOH for improved patient outcomes.

For all of you leaders out there on a value-based care journey, it is not lost on any of you that health value has become synonymous with health equity. We are at an inflection point in our society in the recognition that everyone needs a fair and just opportunity to attain their highest level of health. Achieving this will require ongoing societal efforts to address injustice, overcoming socioeconomic barriers to health, and eliminating preventable health disparities. But we cannot do that as a healthcare industry without the proliferation and scale of payment models that align incentives so we can realize true change for the better. On the Race to Value this week, you will hear from one of the foremost leaders on the national scene who is shaping the landscape for accountable care delivery that can advances health equity. Dr. Dora Hughes is someone who has taken this charge to lead in service to the underserved so that we may realize the dream of a more equitable and healthy society. She is the chief medical officer at the CMS Innovation Center at the Centers for Medicare & Medicaid Services (otherwise known as CMMI). She leads the Center's work on health equity, provides clinical leadership and input on models, serves as the Innovation Center's primary liaison with medical and clinical stakeholders, and provides leadership to the Innovation Center's clinician community. In addition, Dr. Hughes is part of the CMS Innovation Center's Senior Leadership Team, helping to provide enterprise-level leadership and strategic direction to the Center.  In this interview, we discuss the elevated national consciousness to advance health equity, how ACOs and other risk bearing entities can succeed with a health equity strategy, and the work being done by the Innovation Center to redesign alternative payment models for equity.  We spend considerable time discussing ACO REACH and value-based Medicaid transformation as well.  This is certainly a conversation you should listen to as you plan for success in your Race to Value!   Episode Bookmarks: 01:30 Health Value has become synonymous with Health Equity -- everyone needs a fair and just opportunity to attain their highest level of health. 02:30 Introduction to Dora Hughes, M.D., M.P.H., the chief medical officer at the CMS Innovation Center (CMMI) 04:30 If you control for all variables that may contribute to health disparities, African Americans still get the worst quality of healthcare of any demographic in the country. 05:30 The first pillar of CMS' Strategy Plan is Health Equity 06:30 Cara James, Ph.D., president and CEO of Grantmakers in Health: "I'm someone who's working on equity before it became cool to work on equity." 07:00 Referencing the seminal findings of the Heckler Report in the 1980s that investigated racial and ethnic disparities in the United States. 08:00 Momentum has been building towards addressing health inequities, despite the historical lack of national prioritization. 08:30 “It really took the pandemic and police brutality to blast the issues of health inequities into the national consciousness.” 09:00 Disparities go beyond COVID (e.g. black disparities in maternal health, colorectal cancer, kidney disease) 09:45 “Executive pay is now being tied to reduction in disparities. You wouldn't have heard that 10 years ago or even perhaps five years ago.” 10:00 Referencing CCSQ Deputy Jean Moody-Williams: "For those of us engaged in health equity, this is our moment, but it is only a moment." 10:30 Actions Needed: collecting and analyzing demographic and health data,  knowing patients individually and at the population level, identifying disparities, implementing evidence-based interventions. 11:45 “It takes vibrancy, resiliency, and an indomitable spirit to tackle disparities and scale progress at a national level.” 13:00 CMMI's work to address Social Determinants of Health (SDOH), e.g. ACOs, Accountable Health Communities (AHC) Model

Are you ready for the risk-based tsunami on the horizon?  If you are a frequent listener to this show, you understand just how seismic this shift to value-based care really is and why we need the right culture, people, processes -- fueled by capital – to spawn care delivery innovation.  It is in reimagining care delivery that we can truly deliver on the aims of improved outcomes, lower cost, better patient experience, and equity for all populations. Joining us in this Race to Value this week are two outstanding leaders in the value movement, Drs. Brian Silverstein and Yates Lennon.  We discuss how organizations should be preparing for the risk-based tsunami on the horizon through care delivery innovation. Dr. Brian Silverstein is the Chief Population Health Officer for Innovaccer, a leading healthcare technology company committed to helping healthcare care as one. He is an expert in value-based care delivery and health system transformation with vast experience in helping providers improve population health initiatives.  And joining him in this interview is Dr. Yates Lennon, the President of CHESS Health Solutions – a population health MSO empowering physicians and health systems to make the transition to value-based care. Dr. Lennon has extensive experience in quality, practice transformation, and physician engagement and has been instrumental in teaching health systems and providers across the country how to transform patient care and shift to value-based payment. If you are looking to understand the state and science of value-based care, look no further than this conversation with two of the leading minds in industry transformation!   Episode Bookmarks: 01:30 The seismic shift towards value-based care and the risk-based tsunami on the horizon. 02:00 Introduction to Dr. Brian Silverstein and Dr. Yates Lennon 04:30 Progressing in the value journey by understanding the landscape 05:45 Dr. Lennon provides an overview of the value ecosystem with varying adoption of risk in provider organizations. 07:00 “The days of sitting on the sideline are running out.  It is time to get started with value-based care if you haven't already.” 08:00 The State and Science of Digital Maturity at U.S. Healthcare Providers (a recent report from Frost & Sullivan, commissioned by Innovaccer) 09:30 Dr. Silverstein on the legitimacy of the value movement with perspective on how digital infrastructure impacts the pacing of adoption. 10:45 The differentiation of the technology stack utilized by providers accepting full risk-based payment. 12:00 Traversing the value landscape with emerging changes in payment model design focused on the reduction of health disparities. 13:30 Dr. Lennon on how VBP and population health technology tools are perfectly suited to address problems in health disparities. 14:00 Codifying the health equity design of the ACO REACH payment model into operational programs. 14:30 Ensuring access to care in a medical home – an example from Atrium Health Wake Forest Baptist 15:30 “Access is important in value-based care when attempting to address health equity.” 16:00 Focusing on the quality and performance improvement measures that can improve equity. 16:30 Clinical workflow optimization and the use of Community Health Workers to conduct patient outreach. 17:00 Leveraging community resources to address Social Determinants of Health (SDOH). 17:30 findhelp (formerly Aunt Bertha) and Unite Us as examples of technology platforms that can improve SDOH interventions and community partnerships. 18:15 Lifestyle coaching to improve health outcomes with dual eligible populations. 19:00 Dr. Silverstein explains how traditional healthcare will not able to improve population health outcomes in a silo. 20:00 The correlation between a patient's zip code and their overall health and wellbeing. 20:30 Dr. Lennon provides perspective on how the creativity of value-based care will improve models for patient engagement and care de...

In this #SoldierForLifePodcast episode (which is Part 2 of our 3-part series on health benefits for veterans), SFL's Health and Wellness Director, MAJ Katherine Little, talks with with Humana, about Military and Veteran health and How to address health-related social challenges such as food insecurity, financial strain and social isolation. MAJ little is joined by Ms. Andrea Newton, the Director of Military Health and Resilience at Humana and Ms. Stephanie Muckey, Humana's Population Health Strategy Lead | Veteran Bold Goal Community, and Marine Corps Spouse & Caregiver. 

For the 44th episode of the CIO podcast hosted by Healthcare IT Today, we sat down with Dr. Jennifer Goldman, DO, Chief of Primary Care at Memorial Healthcare System. In this episode we're discussing Dr. Goldman's work in Social Determinants of Health (SDoH). First we dive into what she's done to integrate SDoH data into […]

Understanding social determinants of health (SDOH) is fundamental to the work we do in public health to ensure that people can live their healthiest lives. But it can sometimes be hard to explain social determinants fully and succinctly to people outside our field. Whether you are searching for the words to help teach others or you are new to public health yourself and still trying to get a handle on why -- despite educational campaigns and even strong individual motivation and intention -- systemic barriers often prevent people from engaging in healthy behaviors, today's episode is for you!In addition to helping you explain the basics, we'll cover two critically important rules for discussing social determinants of health with people outside public health -- whether partners from other sectors, community-based organizations, decision-makers, even friends and family. And we will also set the stage with this discussion of “Social Determinants 101” for several other related episodes. So enjoy today's show and stay tuned for a whole lot more on social determinants soon!Resources:Social Determinants of Health, Healthy People 2030, published by the U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion.Social Determinants of Health (SDOH), from NEJM Catalyst, Social Determinants of Health (SDOH). Published by New England Journal of Medicine, Dec. 1, 2017.Please click the button to subscribe so you don't miss any episodes and leave a review if your favorite podcast app has that ability. Thank you!For more information, visit the Health Comm Central website at: http://www.HealthCommCentral.com© 2022 Karen Hilyard, Ph.D.

Pharmacy Quality Alliance Chief Engagement Officer Richard Schmitz joins the Quality Corner Show to talk about how pharmacists can get the most out of PQA's Social Determinants of Health Resource Guide.Schmitz explains that the guide focuses on seven key barriers that patients face and that pharmacists can work with their patients to address these barriers by providing Social Determinants of Health (SDOH) services detailed within the guide.More info available at the Pharmacy Quality Alliance website 

Socially Determined Co-Founder and CEO Trenor Williams, MD, talked with Eric about the importance of accessing and unlocking the potential of member demographic data,  including race, ethnicity and language, to identify social risk, and prioritize geographies and interventions for best results, and measure intervention return on investment (ROI).   He specifically discussed how his organization partnered with CareFirst in Maryland on a $10.5 million diabetes prevention initiative. Using the alternative data, Socially Determined defined the communities most at risk to develop diabetes, enabling CareFirst to create targeted solutions that would produce the greatest impact.    About Trenor Trenor co-founded Socially Determined in 2017 and is responsible for leading the company's mission and fundraising activities with strategic investors as well as providing executive oversight to clients. As the son of a social worker, Trenor saw firsthand how the insights his mother gleaned during in-home client visits provided a more holistic story of a person than he ever got as a family physician. Inspired by this experience, he created the company to give organizations full visibility into social risk factors so they could understand its impact on the people and communities they serve and strategically intervene.   Prior to Socially Determined, Trenor was the Medical Director of Family Practice at Mammoth Hospital in California. He went on to serve as Lieutenant Commander in the United States Naval Reserve. This Episode of the Bright Spots in Healthcare is sponsored by Socially Determined   Socially Determined is a physician-founded, Social Risk Intelligence and solutions company, providing risk analytics, data, and advisory services to industry-leading organizations committed to assessing and addressing Social Determinants of Health (SDOH) and social risk among the communities and populations they serve – and bear risk for. Visit their website at https://www.sociallydetermined.com/

In order to implement an effective SDOH strategy, healthcare organizations must develop an infrastructure to integrate both clinical and social interventions. Our panel of experts from Melanin & Medicine, MetroPlus Health, Priority Health, ProMedica, and Socially Determined shares best practices, lessons learned, and key considerations to help you design a roadmap to address social determinants of health (SDOH), social risk factors and social needs among the communities, populations and individuals you serve. Panelist bios: https://www.sharedpurposeconnect.com/events/your-new-sdoh-roadmap-integrating-social-care-into-healthcare/   This episode is sponsored by Socially Determined Socially Determined is a Social Risk IntelligenceTM and solutions company, providing risk analytics, data, and advisory services to industry-leading organizations committed to assessing and addressing Social Determinants of Health (SDOH) and social risk among the communities and populations they serve – and bear risk for. To that end, we offer a purpose-built analytics platform, SocialScape®, to quantify, visualize, and mitigate the impact of SDOH and social risk – at scale.   SocialScape generates community-level SDOH risk exposure indices, individual-level social risk factor scores, and advanced analytics that empower organizations to understand how SDOH and social risk impacts key business metrics, including suboptimal utilization, total cost of care, quality measure attainment, and health equity, as well as member engagement, satisfaction, and retention. Our platform and expertise are trusted by organizations across the healthcare ecosystem including health plans, health systems, life science companies, non-profits, and foundations.

When it comes to improving patient care, Social Determinants of Health (SDOH) solutions continue to be top of mind as the pandemic continues to grip the world. Healthcare organizations all over the US continue to grapple with ways to extend the care of patients beyond the walls of clinics and hospitals. In this episode, we hear from Matt Sabbatino, Managing Director in L.E.K. Consulting's Healthcare Services practice. He provides insights into what has happened with SDOH services during the pandemic and what the outlook is for the future.

In this episode we are joined by Tim Suther, Senior Vice President of Data Solutions at Change Healthcare, to discuss how the healthcare industry is doing with Social Determinants of Health (SDoH), what types of gaps or data fidelity issues are present, where organizations can look to make a significant impact and much more. This episode is sponsored by Change Healthcare.

Factors that make treating NASH and NAFLD a unique challenge for non-Hispanic Black Americans range from Social Determinants of Health (SDOH) to omics suggesting that the disease in Black Americans may be different than in Caucasians or a range of behavioral elements (for example, smoking) that are more closely associated with Black Americans.This conversation begins with Stephen Harrison noting that a combination of lower incidence of Fatty Liver disease within this population and an historically appropriate trust deficit that non-Hispanic Black Americans feel toward medical trials leads to study samples without enough sample to tell us whether a given diagnostic or course of therapy works better or worse in a non-Hispanic Black American population. As a result, he notes, we do not know how negative health behaviors like smoking or alcohol, genomic patterns and comorbidities affect liver health in this population. Later on, Zaki Sherif notes that in omics work in HCC, he and colleagues identified metabolites that upregulated in Caucasians and down-regulated in Blacks. All this culminated in Donna Cryer's point that this is an historic moment to enrich non-Hispanic Black American populations in these trials so that from the moment we begin using these drugs in the general population, we will know how these drugs work among Blacks instead of simply "assuming" they work as they do with other racial groups, only to lear 5-10 years later than this is wrong.

In recognition of Black History Month, SurfingNASH looks at how the impact of NASH on non-Hispanic Black Americans differs from other groups. The episode includes Key Opinion Leaders not only in Fatty Liver disease but also, more broadly, social determinants of health like food insufficiency and clinical trial participation.This episode was originally suggested by Dr. Yani Adere, a Medical Science Liaison at Novo Nordisk and long-time SurfingNASH listener. Yani set the stage for this conversation by noting that while incidence of NASH and NASH cirrhosis may be relatively low among non-Hispanic Black Americans, those who get the disease progress at the same rate as other ethnic groups and, in fact, Fatty Liver is the 2nd leading cause of cirrhosis in this population. She concludes by noting that Social Determinants of Health (SDOH) create undue burdens for Black Americans with liver disease as with other diseases.Donna Cryer, Founder and CEO of the Global Liver Institute followed Yani. First, she noted that since NASH has a limited history as a disease, it offers the chance to create history by building health equity into clinical trials and patient treatment as initial protocols and guidelines come into force, "instead of waiting 5-10 years" as with other diseases.Dr. Zaki Sherif of Howard University raised an important point about Liver Disease in this community: while non-Hispanic Black Americans progress from liver to cirrhosis slowly (as do other groups), the speed at which they progress from cirrhosis to HCC is faster...and Black Americans are less likely and slower to receive liver transplants.Dr. Ani Kardashian of USC, a transplant hepatologist and national leader on the issue of food insufficiency, began her comments by nothing that while Fatty Liver disease is not as common in Black Americans, outcomes are poorer. Ani raises the issue that some of the poorer outcomes might result from lower levels of patients in clinical trials, which is a challenge with many diseases.From here, the discussion heads off in several different directions, all of which confirm the point that the intersection of relatively low incidence, other diseases with higher prevalence and severe outcomes and the range of SDOH issue leads to a situation where patients receive less treatment and support than other sub-populations. The group discusses some of the major challenges and posits possible solutions.

Four years ago, Dr. Phil and Gerry started Food First Michigan with the intent of changing the conversation about food security in Michigan. The reason we can see farther is because we've been standing on the shoulders of giants - giants that have joined the movement of creating a food secure state. This charge is born out of believing food insecurity CAN be solved and that it is in the best interest of EVERYBODY in the community for it to be solved. Tune in for Food First Michigan this Sunday at 9:00 PM on WJR Radio with Dr. Phil Knight, Gerry Brisson, president and CEO of Gleaners Community Food Bank, and John Roberts, interim president of Advantasure and a member of the Food Bank Council of Michigan Board of Directors, to hear why John has joined our movement and discuss the importance of the Social Determinants of Health [SDoH]. John is an influencer - a leader who has served at the top levels of State Government and is unafraid to help others when they are in need. Food is centric to our lives and we believe that food insecurity is an issue that can unite us – it is a non-partisan issue that drives change! Where there is no vision, the people perish. But, where there is no money, the vision perishes. John got involved in this movement because he wants a community that is equitable and thrives. He has come alongside of us in many ways. Leaders are influencers. When people who lead want to use their influence for the greater good and the welfare of others, it is impactful! Find this episode and all past Food First Michigan episodes at foodfirstmi.org, on Apple Podcasts or iHeartRadio. Apple Podcasts --> https://apple.co/38UUpFk iHeartRadio --> https://ihr.fm/38WJ2wN #FOODFIRST #FoodFirstMI #FoodSecurity #MoreFoodMoreOften2MorePeople

Social determinants of health (SDOH) are social risk factors—like food insecurity, housing instability, or poor health literacy—that have an impact on overall health. Our guest, Trenor Williams, is the CEO and Co-Founder of Socially Determined, a technology company that measures the impact of SDOH and combines those analytics with clear steps businesses can take to address them. In this episode, Trenor shares the origins of the company, the challenges they've overcome, and the tangible results they've delivered. We discuss: The origin story of Socially Determined The challenge of turning raw data into meaningful insights The company's transition from delivering insights to prescribing action The evolution of the SDOH space Stay connected with In the Worx by subscribing onApple Podcasts,Spotify, or your favorite podcast player. Check out our website athealthworx.com. If you have any suggestions for topics to feature or innovators who are pushing healthcare forward, contact us at comms@healthworx.com. 1. Guests invited to speak on the podcast are not employees of Healthworx, LLC (hereinafter, “Healthworx”) or its affiliates. The views and opinions of guests are their own and do not necessarily reflect the views and opinions of Healthworx, its management or company as a whole, or its affiliates. 2. [If you have medical professionals on the podcast] Information provided is not medical advice, is not meant to be interpreted as medical advice, and should not be accepted as such. Listeners should consult with their own physician or other medical provider if they have any health concerns or questions. 3. The mention of any products, methodologies or companies does not constitute an endorsement by Healthworx or any of its affiliated entities of such product, methodology or company. 4. Except for personal use or education, no one should reuse, republish or reprint the information contained in this podcast or the podcast itself without Healthworx's consent. Please contact comms@healthworx.com with your request.

Social Determinants of Health (SDoH) is a concept with tremendous potential to improve the overall health and wellbeing of human beings. However, it appears to have found more room in academic conversations than in the real world. The idea is to leverage elements that impact of health such as education, financial stability, a sense of community and safe neighborhood to maintain a level of health and to support better health outcomes when healthcare is required. We explore that possibility and vehicles for change in this videocast with experts in the field. This videocast has 3 parts: 1. Setting the stage – Understanding the potential of social determinants of health and what it is. 2. Let's talk unfiltered – Exploring how SDoH can manifest in the real world and the types of solutions that can show a difference to our health. How are health plans and technology enterprises sieging on the opportunities of SDoH? How can emerging technologies shape the operationalization of SDoH and its impact on the triple aim of healthcare? SDoH an academic construct or a real-world change maker? 3. Looking into the future – Polarization in the US is getting worse, however, could our focus on SDoH mitigate its impacts? Also, what can SDoH do to help us reverse climate change?

Determining Family Resilience with Dr. Jason Yaun, Medical Director of the Family Resilience Initiative at Le Bonheur Children's Outpatient Clinic Join me for an informative conversation with Dr. Jason Yaun. Dr. Yaun is the Medical Director of the Family Resilience Initiative (FRI) at Le Bonheur Children's Outpatient Clinic in Memphis, Tennessee. The FRI is an initiative that aims to intervene with children and their families in the Social Determinants of Health (SDoH) and Adverse Childhood Experiences, or ACEs. The FRI serves families with children 9 months to 5 years of age. These families are connected with Outreach Coordinators as part of routine care and various interventions are implemented based on answers from the ACEs questionnaire. As part of the care, families may be connected with a psychologist or other services offered by Le Bonheur Children's Hospital and other services available in Memphis and surrounding communities. Dr. Yaun talks about the goals of the FRI and supporting families and “meeting them where they are” in their life and circumstance stage. The FRI is making connections for families and hopes to provide a model for other clinics to be able to follow. More About Dr. Yaun:Dr. Jason Yaun is an Associate Professor of Pediatrics at the University of Tennessee Health Science Center in Memphis, Tennessee. He is the Outpatient General Pediatrics Division Chief and the Medical Director of the UT Le Bonheur Pediatric Specialists General Pediatrics Clinic at Le Bonheur Children's Hospital, which serves as the academic teaching practice for UTHSC. Dr. Yaun was born and raised in Memphis, completing medical school and residency training at the University of Tennessee before joining the faculty there. He is currently the Vice President and President-Elect of the Tennessee Chapter of the American Academy of Pediatrics. In addition to his clinical duties, Dr. Yaun is involved with education, clinical research, and advocacy. He has authored papers on improving vaccination rates, early literacy promotion in primary care, and currently has grant funding for ongoing work to research adverse childhood experiences. In the community, he serves on the boards of Books from Birth Shelby County and Literacy Mid-South.Links to Dr. Yaun's Bios: https://www.lebonheur.org/doctors/jason-yaun/ https://www.uthsc.edu/faculty/profile/?netid=jyaunFollow Dr. Yaun on social media! Twitter: @JasonYaunMD and LinkedIn: JasonYaunMD.Information on ACEs:https://www.cdc.gov/violenceprevention/aces/index.html https://acestoohigh.com/got-your-ace-score/ Still Face experiment video link: https://youtu.be/apzXGEbZht0 Tennessee's Building Strong Brains Initiative: https://www.tn.gov/dcs/program-areas/child-health/aces.html#:~:text=Building%20Strong%20Brains%3A%20Tennessee%20ACEs,the%20most%20promising%20approach%20to About That's Healthful:The “That's Healthful” podcast is hosted and produced by Dr. Lisa Beasley, a Family Nurse Practitioner, and an Assistant Professor with the University of Tennessee Health Science Center College of Nursing. Visit https://thatshealthful.com/ for more information or to hear prior episodes. Follow @nowhealthful on Twitter and thatshealthful on Instagram. Like or comment on an episode wherever you listen or stream your favorite podcasts.Music for this episode is provided by local Memphis singer, musician, and songwriter – Devan Yanik. For more of Devan's music visit https://devanmusic.weebly.com/

In this Social Determinants of Health (SDOH) episode, Dr. Deepak Vadehra (Roswell Park) moderates a discussion with Dr. Carmen Guerra (Abramson) and Dr. Daniel Carrizosa (Levine) on how access to care impacts SDOH and the available interventions and resources that can mitigate these issues for patients. View COI & Cancer.Net Podcast. Subscribe: Apple Podcasts, Google Podcasts | Additional resources: education.asco.org | Contact Us Air Date: 10/28/2021

This episode is a recording of NACHC's September webinar focused on the continued impact of Social Determinants of Health (SDOH) on our communities and the strategies and partnerships health centers are developing and cultivating to address them head-on. The discussion featured: * Cameron Webb, MD, JD, Senior Policy Advisor for Equity,  White House COVID-19 Response Team  * Andrea Caracostis, MD, MPH, CEO - HOPE Clinic (TX) Rashad A. Collins, COO - Charter Oak Health Center, Inc. (CT) * Antony Stately, PhD, CEO - Native American Community Clinic (MN) View the video of this discussion: https://www.youtube.com/watch?v=a0ai6KuHRtg This is the eighth installment of our monthly webinars offered as part of our “Propelling Our Mission Forward in NACHC's 50th Year” series. View past webinars and learn about upcoming webinars.    

In this Social Determinants of Health (SDOH) episode, Dr. Jacquelyne Gaddy (UNC-Chapel Hill) speaks with Dr. Marvella Ford (Medical University of South) and Dr. Jennifer Ligibel (Dana-Farber Cancer Institute) on obesity and energy balance as modifiable risk factors and how clinicians can respectfully engage with their patients on this topic. View COI. Subscribe: Apple Podcasts, Google Podcasts | Additional resources: education.asco.org | Contact Us Air date: 9/29/2021   TRANSCRIPT [MUSIC PLAYING] LORI PIERCE: Hello. I'm Dr. Lori Pierce, the 2020-2021 president of the American Society of Clinical Oncology. Thank you for tuning in for this discussion on social determinants of health and their impact on cancer care. The purpose of this video is to educate and inform. It is not a substitute for medical care and is not intended for use in the diagnosis or treatments of individual conditions. Guests on this video express their own opinions, experiences, and conclusions. These discussions should not be construed as an ASCO position or endorsement. For this series on the social determinants of health, we invite guests with a wide range of views and perspectives. Some of these conversations may be provocative and some even uncomfortable. But ASCO is committed to advancing equitable cancer care for all individuals, every patient, every day, everywhere. I dedicated this vision to my term as ASCO president, and these conversations bring many voices to the table, voices that we need to hear to move forward and find solutions. We hope you learned new ways of thinking about these issues and we invite you to join us in working toward a world in which every person with cancer, no matter where they live or what resources they have, receives high quality equitable cancer care. Thank you. JACQUELYNE GADDY: Welcome to the ASCO Social Determinants of Health Series. I am Dr. Jacquelyne Gaddy, and I'm a current third year fellow in the Division of Oncology at UNC Chapel Hill. With me today is Dr. Marvella Ford, endowed chair of cancer disparities from the Medical University of South Carolina and South Carolina State University, and I also have the pleasure of having Dr. Jennifer Ligibel, director of the Zakim Center for Integrative Therapies and Healthy Living at Dana-Farber Cancer Institute. In this episode, we will be discussing obesity and energy balance as modifiable risk factors, and how clinicians can respectfully engage with their patients on these topics. Dr. Ligibel, we've had some time talking together. And I want to start by actually just getting an introduction of how we can actually relate cancer and the outcomes of cancer with this topic today of obesity. JENNIFER LIGIBEL: Sure. This is definitely a topic that we've learned a lot about, especially within the last few decades. We recognize that obesity is an epidemic, not just in the United States, but everywhere. In the US, many adult populations across various states have a prevalence of 40% or more of the adult population having obesity. And this rate is rising around the world. And we've known for a long time that obesity increases the risk of a lot of diseases, heart disease, diabetes. The connection between obesity and cancer is something that we have recognized more recently. And in fact, in 2016, the International Agency for Research in Cancer reviewed all of the data looking at the relationship between excess adiposity, whether it was measured through BMI, through body composition and the risk of developing cancer, and found that there were 13 different cancers for which there was a clear and consistent relationship between higher levels of obesity and higher levels of cancer. We also know that there's a relationship between a number of factors that contribute to excess adiposity, things like inactivity and poor dietary quality and excess cancer risk. We also know that individuals with obesity face increased challenges after cancer diagnosis. There are higher incidences of things like surgical complications, neuropathy, and other side effects of cancer therapies. And for many diseases, individuals with obesity at the time of cancer diagnosis have an increased risk of cancer recurrence and mortality as compared to leaner individuals. So we know that there is a strong relationship between obesity and the risk of developing cancer and the risk of dying from cancer, as well as suffering increased toxicity from cancer treatment. JACQUELYNE GADDY: Thank you for that, Dr. Ligibel. That gives us a really introduction into this important topic. And Dr. Ford, if we can dive a little bit deeper, I know this past summer for our ASCO conference, I had the pleasure of listening to you as you presented. And I wanted to specifically ask you to address what you discussed in regards to inflammation and its relation to cancer and obesity. MARVELLA FORD: Yes, absolutely. So as Dr. Ligibel just noted, there is an association between being overweight and likelihood of being diagnosed with cancer, and also, the cancer treatment outcomes. What we have seen is that there's an underlying association between bile inflammation. The same bile inflammation that is linked to heart disease is also linked to cancer. And the good news is that there's something that we can do about it. So when we talk about the modifiable behavioral health risks, this is one of them. What we're seeing is that physical activity can actually reduce levels of bile inflammation in the body, which is great news. And Dr. Ligibel and others around the country are leading the way in developing physical activity interventions for people who are diagnosed with cancer so that we can intervene early on to develop strategies to improve their cancer treatment outcomes. You know, that leads us to the broader question of physical activity for the general population. How can we increase physical activity for everyone to reduce cancer risk? And I think there are some very attainable goals that we can set and there are some strategies that are achievable that we can accomplish in that arena. JACQUELYNE GADDY: As we think about the social determinants of health and why we got started with this, and Dr. Pierce did an amazing job of putting that at the forefront of ASCO's goals this past year during her presidency, before we dive even deeper, Dr. Ford, I want you to address specifically, you had a wonderful figure. And I can kind of see it in my mind right now in regards to the race maps when addressing obesity, and again, tying that back into its relation to cancer. MARVELLA FORD: So when we talk about obesity, what we don't want to do is get into a blaming-the-victim kind of approach where, oh, these people are just so overweight, that is exactly what we do not want to do. It's really important to look at the social determinants of health and the contributors to overweight and obesity. Because people are working with what they have available to them. And so the map that you're talking about really highlights the social determinants of health in relation to obesity. And so what we saw-- I showed a series of maps-- is that obesity in the US, it's associated with race but it appears to be driven by socioeconomic position. So areas that have lower levels of income, education, you know, upward mobility is what we used to call it, have higher rates of obesity. And a lot of that is due to what's in those communities. And so if you drive around those communities, whether they're rural or urban, you see a lot of fast food places. You see a lot of food deserts. Food deserts are not just a purview of inner cities, urban areas, rural areas where you would think, well, that's ironic because food is grown in the rural areas. But rural areas can also be food deserts. And so in my work at the Hollings Cancer Center, we're focusing a lot on the I-95 corridor of South Carolina, which ranges from North Carolina at the top, to Georgia at the lower end. And I know that's been an area of interest to many in our state. And what we have seen is that it's one of the poorest and most medically underserved areas of our state. And if you just do a visual exam, if you drive on the I-95 corridor and just get off on some of the side roads, you see just a dearth of healthy foods, grocery stores. There are convenience stores. There are gas stations. I call it gas station food, convenience foods, where you can eat to fill up. But it's not really healthy food and it's not life-affirming, life-promoting, life-enhancing food. And so this is what people have available to them. We have seen this with the impact of COVID-19 on the school systems. What we're seeing is that the schools, even if they're closed due to COVID, they still have to remain engaged in food distribution. Because for a lot of the children, the meals that they had at school may have been the only meals that they had that day. And so kudos to the school systems around the country for continuing to distribute healthy food to the children even when school is not physically in session, even when they're in a hybrid model or a virtual model. And on the weekends, they're sending kids home with backpacks full of healthy foods. I just spoke with a principal on Friday. One student tested positive at a local high school, and so she had to inform the other students who were in contact with that student that they had to get sent home. And one young lady was crying and said, but I want to stay in school. And there are a lot of reasons, and one of them is food security, being able to eat healthy foods and having access to healthy foods. Healthy foods can help to reduce inflammation in the body. But we also know that there are stressors that are associated with the social determinants of health that also raise levels of bile inflammation, stress, stressors. What are the stressors associated with the social determinants of health? The same stressors that we're experiencing in this pandemic. The pandemic is really highlighting the stressors that many people in the US have lived with on a daily basis for decades. Job insecurity, food insecurity, housing insecurity, educational insecurity, not knowing whether if the rent increases by $30 in one month, it may not seem like a lot, but if your budget is already stretched really tight, you may not be able to make a $30 increase. And then, if you and your family are living in your car, how does that impact healthy eating, and how does that impact stress? And so all of these factors combined, there's kind of an interactive multiplicative effect on increasing levels of stress and stressors that people are facing. And again, the good news is that physical activity can help to lower those levels of bile inflammation. And I think we just need to be cognizant of where people are when we develop interventions and start with where they are in what's available and accessible to them in order for the interventions to really be successful. JACQUELYNE GADDY: Thank you for that, Dr. Ford. And I think you touched on a lot of different barriers that I know I can attest as a fellow and been in training for so long, and I know Dr. Ligibel can also likely attest to that as well. I'm from Buffalo, New York, a rather urban environment. And you know, my mom raised me as a single parent mother. So many of these barriers that you're describing I either experience personally or definitely have close friends, et cetera, that did have these barriers. Dr. Ligibel, I want to ask you in your day-to-day practicing, outside of the barriers that Dr. Ford addressed, what do you tend to see on a day-to-day basis that are common barriers that patients face when they're battling obesity? JENNIFER LIGIBEL: I think that's a great question. And I will say that one of the things that we've been doing through ASCO for the last few years through our work in the obesity initiative is trying to learn a bit more about what's happening in practice. What are patients hearing? What are doctors saying? And so in 2019, we conducted a survey that went out to all of ASCO membership asking anyone who actively participates in clinic, whether they were a physician, a nurse practitioner, a chemotherapy nurse, kind of all through the entire health team, do you talk to your patients about physical activity, about nutrition, about their body weight and how that may be connected to cancer? Now this was a survey, so the people that responded were very interested in this topic. And most of them indicated that they did talk about these topics with their patients. But they noted that they felt like they didn't have a lot of training in what's the best way to bring up these topics. And we asked them specifically, what do you think are barriers to patients making healthy lifestyle changes after cancer diagnosis? And one of the things that they said, certainly, barriers in terms of transportation and resources. There's just-- many places don't have physical activity programs to send their patients to. But they also talked about that patients weren't aware that this was an important part of their health, and that this really needed to be a message that was echoed many times, not just by one provider. So we followed up that survey to providers and asked patients, what are you hearing about nutrition and exercise from your cancer care providers? And not surprisingly, because this was patients that were also interested in this, they all said they wanted to hear about this. And only about half of them actually got any kind of information about a healthy diet or exercise or weight management from their providers. And so I think that there's clearly work that we still need to be doing, trying to figure out, how do you help providers talk about these things with their patients? How do you help patients make these types of healthy lifestyle choices after cancer diagnosis? Because there are a lot more barriers than for someone who's thinking about making changes in their activity before cancer diagnosis related to their cancer. They may be more tired. They may have side effects like neuropathy or lymphedema. In addition to all the things that Dr. Ford talked about, cancer creates a lot of economic uncertainty for people. And that can contribute to not thinking that you've got the resources to be able to make these healthy lifestyle changes. So I think there's a lot of work to be done both in the messaging and then having the services available to people to make it easier for people to choose healthier foods, to have the ability to exercise in a safe place. We have a long way to go to really make these things be accessible to our patients. JACQUELYNE GADDY: Thank you, Dr. Ligibel. Dr. Ford, you have talked about this during this conversation. And you have previously mentioned this as far as your research is concerned. As we consider the solution, because that's the biggest part, right? We can talk about the problem all day, and I think we tend to do that a lot in research. But what is more important and most important in my eyes are what are we going to do about it? As we think about all of the things that Dr. Ligibel just mentioned, what are the parts from a structural racism standpoint that are lacking, that you think A, is a problem-- so we need to identify it-- and then also, as we transition into the last part of this conversation is, what are we going to do about it? MARVELLA FORD: That's a really great question, because that's really the ultimate question, right? What are we going to do about it? And so I think that you and Dr. Ligibel have alluded to the fact that we want to make sure that the interventions are successful, these physical activity interventions. And so that means starting with where the patients are. If we are working with a patient population that already was struggling financially before a cancer diagnosis, we have to recognize the impact of that on their lives of the cancer diagnosis, on their economic stability after. And even people who had really great jobs before a cancer diagnosis, depending on where they worked, they may or may not have the benefits that would continue to sustain them over time, over the course of the cancer treatment. So their lives may take a drastic shift as well. And so I think that what we want to do is recognize what the patients are going through on a daily basis. And it would be wonderful to be able to offer at our cancer centers, people come for treatment. Can we do physical activity at the cancer centers? I know some are starting to do different types of exercise. But this would be something that they could bring their children to, they could bring their families so they wouldn't have to worry about child care. I know our cancer center at one point offered Middle Eastern dancing, or belly dancing. And it was just great. People could bring their kids. I participated. Even before my own breast cancer diagnosis, I participated. And it really helped the women to regain mobility and use of their arms, being able to raise their arms over their heads after a breast cancer treatment. And so it really-- I think the exercise could be tailored to the needs of cancer patients as they recover. And as they continue to go through treatment and recover, you can tailor the specific types of exercise to their needs. Most of our cancer centers have some type of wellness facility. And so I know that at our wellness center, we have a physician, Dr. Jennifer Harper, who started a physical activity program for breast cancer survivors. And it's gone on for, I think, at least five years. And so it's really great if we can build on the resources that we have in our centers, and our cancer centers, out in the community. If we partner with local schools, have gyms. A lot of them open up after hours to the community members so they can bring their children and everyone can exercise together. But we could bring in people with training with cancer survivors to work on physical activities that are specific to certain types of cancer to help improve outcomes for those cancer types just by partnering with local schools. So I think there are a lot of things that we could do, making use of existing resources in our communities, doing a lot of partnerships, partnering with fire departments, partnering with people in the community who can become champions and can help drive it. JACQUELYNE GADDY: Thank you for that, Dr. Ford. And lastly, Dr. Ligibel, we talk about-- in the Black community, a common thing that we mention is the Brown tax. But then when we consider the intersectionality of the Brown tax with those that are obese and that stigma that's associated with it. Lastly, what do we do to try to address that stigma? Because I think patients come in, they're already fearful about their diagnosis. And then some are fearful because the color of their skin. And now they're obese as well. How do we tackle that as providers and trainees? JENNIFER LIGIBEL: That is a phenomenal question. And there are many data that show that people with obesity are less likely to seek medical care. They're diagnosed with cancers at a later stage. And a lot of that is due to that feeling of, I don't really want to engage with the system. I don't feel good when people are talking to me about my weight. And I think this is a place where we really need some concentrated training. There are many subspecialties where this is already being worked upon. And I think that this is, again, something that as an oncology community, we need to think about how to treat our patients with respect and create an environment where people feel comfortable. Because therapeutic partnership with your cancer provider is so important, that people have that sense of being cared for. And I think this is really something that we can work on together. JACQUELYNE GADDY: Dr. Ligibel and Dr. Ford, it's been a pleasure working with you before this and during this. I want to thank you both for taking time to speak with me today. And I want to thank you for joining us for this episode of the ASCO Social Determinants of Health Series. To keep up with the latest episodes, please click Subscribe. Let us know what you think about this series by leaving a review or by simply emailing us at professionaldevelopment@asco.org. Thank you. [MUSIC PLAYING] SPEAKER: Thank you for listening to this week's episode of the ASCO e-learning weekly podcast. To make us part of your weekly routine, click Subscribe. Let us know what you think by leaving a review. For more information, visit the comprehensive e-learning center at elearning.asco.org.

Matthew welcomes Evelyn Gallego, CEO and Founder of EMI Advisors and Program Manager for HL7 Gravity Project, a multi stakeholder public collaborative that develops consensus based data standards for Social Determinants of Health (SDOH). Evelyn discusses the history of the project, it's successes and challenges they face as it helps the industry marry social services and clinical services. 

Host: Mindy McCulley, Extension Specialist for Instructional Support, University of Kentucky  Guest: Dr. Natalie Jones, Extension Specialist for Family Health Episode 6, Season 4 Social Determinants of Health (SDOH) are all around us and they affect our health, just as what we eat, how we exercise, or what health conditions we might experience.  On this episode of Talking FACS, Dr. Natalie Jones breaks down the Social Determinants of Health into smaller information chunks to make them easier to process and help us think about ways we can use the information to impact our lives. For more information: Explore the CDC: Social Determinants of Health: Know What Affects Health HealthyPeople.gov. Social Determinants of Health Healthy People 2030, U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion

In this Social Determinants of Health (SDOH) episode, Dr. Narjust Duma (DFCI) moderates a talk with Dr. Danielle McCarthy (University of Wisconsin-Madison) and Dr. Erica Warner (Harvard Medical School & MGH) on tobacco cessation as a modifiable risk factor and how clinicians can respectfully engage with their patients on this topic. View COI. Subscribe: Apple Podcasts, Google Podcasts | Additional resources: education.asco.org | Contact Us Air Date: 8/26/21

In this episode of the Social Determinants of Health (SDOH) series, Dr. Shekinah Elmore (University of North Carolina at Chapel Hill) and Dr. Ramy Sedhom (Johns Hopkins University) provide research highlights in Social Determinants of Health topics from the recent 2021 ASCO Annual Meeting, provide context to the research, and discuss clinical implications. View episode slides and COI. Subscribe: Apple Podcasts, Google Podcasts | Additional resources: elearning.asco.org | Contact Us Air Date: 7/21/2021   TRANSCRIPT [MUSIC PLAYING] LORI PIERCE: Hello. I'm Dr. Lori Pierce, the 2020-2021 president of the American Society of Clinical Oncology. Thank you for tuning in for this discussion on social determinants of health and their impact on cancer care. The purpose of this video is to educate and inform. It is not a substitute for medical care, and is not intended for use in the diagnosis or treatments of individual conditions. Guests on this video express their own opinions, experiences, and conclusions. These discussions should not be construed as an ASCO position or endorsement. For this series on the social determinants of health, we invite Guests with a wide range of views and perspectives. Some of these conversations may be provocative, and some even uncomfortable. But ASCO is committed to advancing equitable cancer care for all individuals, every patient, every day, everywhere. I dedicated this vision to my term as ASCO president, and these conversations bring many voices to the table-- voices that we need to hear to move forward and find solutions. We hope you learn new ways of thinking about these issues, and we invite you to join us working toward a world in which every person with cancer, no matter where they live or what resources they have, receives high-quality, equity for cancer care. Thank you. SHEKINAH ELMORE: Hi, and welcome to the seventh episode of the ASCO Social Determinants of Health Series. I'm Dr. Shekinah Elmore, and I'm an assistant professor of radiation oncology and urology at UNC Chapel Hill. With me is Dr. Ramy Sedhom, a medical oncology fellow at Johns Hopkins. We're happy to be joining you, wherever you are in the world. RAMY SEDHOM: Yes, absolutely. This series is part of an initiative proposed by ASCO president Dr. Lori Pierce, focused on increasing oncologists' understanding of the social determinants of health, its impact on patients, and modifiable risk factors for cancer, inspired by Dr. Pierce's presidential theme of equity, every patient, every day, everywhere. In this episode, we will review highlights in social determinants of health topics from the recent ASCO annual meeting, provide context to the research, and discuss clinical implications. SHEKINAH ELMORE: In the social determinants, some of us might need a refresher, and that's OK, too. So the social determinants, as most of us know, are really those things at the interpersonal, community, social, structural higher levels that pattern health outcomes and access. So it's education, it's health care, its neighborhood and built environment, social and community context, and economic stability in one model from Healthy People 2030. But what we'll be talking about in many ways is at the individual level-- so the individual social risk factors that are lower than the social determinants of health. And then we'll also be talking a lot about race and racism. And so in terms of racism, the best definition that I have found is by Dr. Ruth Wilson Gilmore. She's a noted geographer. And that definition is that racism is the state-sanctioned or otherwise extralegal production and exploitation of group-differentiated vulnerability to premature death. And one of the benefits of the podcast format is that you can rewind, fix yourself on this slide, and read the definition a few times, like I did when I first came upon it, to just see how straightforward, but how all-encompassing, it is. And so racism is really a structural determinant of health. It sits above even some of these social determinants that we talk about. It patterns health inequities directly. It also has these interactions with all of the social determinants of health. And I think that that will become clear with the abstracts that we're talking about. RAMY SEDHOM: Really, really powerful definitions. And with regards to care access, almost 40 years ago, Penchansky and Thomas published their five As of access framework. And the five As, as you can see here, represents affordability. So thinking about what is the cost to patients. And there's been a lot of work coming out over recent years showing that these costs are increasing for patients directly with time. Accessibility-- what is the distance to location or a particular service for patients throughout the country. Availability-- what is the access to specialists and specialty resources, accommodation, flexible scheduling, and acceptability. And the reason why we bring up this framework is it's a context to discuss the first of the abstracts that we will discuss coming from Dr. Guerra and colleagues at the Penn Abramson Cancer Center. While published 40 years ago, these issues remain pertinent today. And we know that clinical trials do not operate in a vacuum, but instead mirror a lot of the problems within our current health care infrastructure. And that's what makes this work most impressive to me. I do encourage all to listen to the oral presentation from the ASCO annual meeting, abstract number 100, titled "Accrual of Black Participants to Cancer Clinical Trials Following a Five-Year Prospective Initiative of Community Outreach and Engagement." So what was the problem they were tackling? The team identified a major gap for full inclusion of minoritized patients in their cancer clinical trials network. And their goal, as highlighted by this abstract, was to increase the accrual of Black participants in cancer clinical trials. Importantly, they took a multilevel approach. But before thinking about any intervention, they went out into the local communities. They spoke to the patients, to the community leaders, pastors, community advocacy groups, and outreach groups to really listen to what the problems were. And by engaging with those most important stakeholders, did they really think about what were the most important interventions? And what did these interventions look like? Well the team at the Penn Abramson Cancer Center focused on educational efforts in Black communities dispelling many myths about cancer clinical trials. They also increased touch points and access points for patients to access care. Most importantly, these came through breast cancer and colon cancer screening for both insured and uninsured patients. One thing that really stuck out to me, very pragmatic and thoughtful in its design, was to make sure that culturally-tailored marketing strategies were also available for patients to see. They worked with pharma to make sure that Black patients were also shown on pamphlets discussing cancer clinical trials. And when thinking about access to care, we know that transportation is oftentimes a barrier, especially for our most vulnerable patients. So they had made sure to have contracts and connections with Lyft and other ride-sharing agencies to make sure that people can make it to the cancer center. And from the health care infrastructure side, they established new requirements for minority accrual plans, and made sure to use community health workers and one-on-one patient navigation. And what was the ultimate impact of their work? Over a five-year effort, they reached more than 10,000 individuals through various venues. And when looking at their primary outcome, they more than doubled the number of Black patients who were accrued on cancer treatment trials. And they saw up to a four-fold increase in the accrual of Black patients in non-intervention treatment trials. However, what is most important is they established a new level of trust with patients in communities that they were not before reaching. And they were able to remodel their organizational care delivery infrastructure to address this major gap in care delivery. So what was the hallmark of the strategy and how can we pragmatically implement it in our own institutions? First, they focused on understanding local needs. Importantly, they established bidirectional relationships, and they made sure to acquire data to show the business case for why this is a return on investment for patients, their local city, and their health care infrastructure. I want to applaud Dr. Guerra and her team for making sure that this was a long-term investment in the Philadelphia area. What first started as a research grant later grew to involve the entire cancer service line, all the way with the director of the cancer center, and making sure to involve their entire organization. And what is the lesson learned? Well, Black participants are significantly underrepresented in clinical trials. But it is not because they are resistant to participating. Instead, this is likely due to structural, clinical, and organizational barriers. In our local communities, the underrepresented minoritized groups may look different. Perhaps they may be racial minorities. They may be rural dwellers, adolescents, or perhaps elderly patients, sexual and gender minorities, and so on and so forth. So I'd like to open this up to Dr. Elmore, and see if you have any other comments or thoughts from hearing about this. SHEKINAH ELMORE: This is such tremendous work. And I agree. I think that it's a testament to so many things. I think that responsive development of interventions is so critical, and that truly, Black patients and Black people want to be included in the things that are meaningful to changing health outcomes. And there's so much here, and I really hope to see more efforts like this in both trial enrollment and for standard of care enrollment. RAMY SEDHOM: Absolutely, and hats off for ASCO advocacy for really pushing forward the CLINICAL TREATMENT Act, which made sure to ensure that clinical trial costs were also covered. This was a landmark decision that came in December of this previous year. [AUDIO OUT] area. And we look forward to seeing this implemented on a larger scale through partnerships with ASCO in future years. And with that, I'd like to transition to our next abstract that Dr. Elmore will lead us through. SHEKINAH ELMORE: Great, thanks. So this abstract, "Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial Participants," the first author is Dr. Subha Perni and the last author is Dr. Ryan Nipp, both of which I know well from MGH. And so the problem here that they were trying to address and explore is that trial participants are at high risk for adverse effects from financial toxicity. But we don't really know that much about what the scope and type of those adverse events might be. So with this study, they prospectively enrolled trial participants from MGH for about two years, and they saturated their sample with those that were already referred per their request for financial assistance. And so they assessed financial toxicity in these two ways, both asking these participants about financial burden overall of care, and then focusing in on trial cost concerns. And then they also asked, using standardized validated measures, about patient-reported outcomes. So physical and psychological symptoms, illness perception, and communication confidence. How confident are they in communicating with their care teams? The results are interesting. 200 patients-- so 57% in this group noted that they had financial burden overall, and 41% with trial cost concerns. Those that noted financial burden were more likely to be young patients, which makes sense. And trial cost concerns, those were more frequent among patients with lower incomes. Both of these were significant, and I think that that speaks to the validity of these constructs of financial toxicity. And then this is the most interesting part. Financial toxicity was associated with greater physical and psychological symptom burden, negative illness perception, and lower communication confidence. So the bottom line here is that financial toxicity was associated with worse patient-reported outcomes across all domains that were measured. Lots of future questions here. So how might financial toxicity operate in different clinical settings? These are trial participants at a designated cancer center. How does that work in community oncology practices or among non-trial participants? How might financial toxicity moderate some of those other social risk factors or social determinants of health? We know from other health outcomes that if you look at Black Americans and white Americans with the health outcomes disparity, that disparity sometimes widens as you climb socioeconomic strata. And then how might financial toxicity influence oncologic outcomes? More physical symptom burden, more psychological symptom burden, worse communication, that could all lead to worse oncologic outcomes. So lots of programmatic implications here. I think prospective identification of financial toxicity risk, those patients who are at risk for that, and then aligning that with social and economic interventions. But this certainly aligns with the previous abstract that we discussed, another lens on why people might not participate in trials, and just the financial burdens that care can bring to patients, and the fact that it impacts the very care that they're getting. RAMY SEDHOM: Yes, absolutely. Such great work by Dr. Perni and Dr. Nipp and their team. I think we're just scratching the surface, as you mentioned, with financial toxicity and its implications on patient care and the caregiver experience as well. So all in all, I think the concluding remarks we could probably make is that equity is a simple concept to grasp, but very complicated to execute and measure for success. We do want to thank our authors who did put time and effort in their careers to opening up our eyes, and Dr. Pierce for really making this the highlight and the theme of her tenure as ASCO president. So for those listening in, thank you for joining us for this episode of the ASCO Social Determinants of Health series. To keep up with the latest episode, please click Subscribe. Let us know what you think about the series by leaving us a review or by emailing us at professionaldevelopment@asco.org. On behalf of Dr. Elmore and I, thank you for listening in. SHEKINAH ELMORE: Thanks. [MUSIC PLAYING] VOICEOVER: Thank you for listening to this week's episode of the ASCO eLearning weekly podcast. To make us part of your weekly routine, click Subscribe. Let us know what you think by leaving a review. For more information, visit the comprehensive e-learning center at elearning.asco.org.

Great health care doesn't end when a patient leaves the doctor's office. Social Determinants of Health (SDOH) are the unseen social factors that affect a person's health, like where they live, what they eat, and even their education level. Learn more from expert, Nebeyou Abebe, about how health care and insurance providers can address SDOH to treat the member's whole health. Featuring: Nebeyou Abebe, Senior Vice President of Social Determinants of Health and Lori Schoonmaker, Market President of National Markets at Highmark. The views and opinions expressed in this program are those of the participants and do not reflect the views or opinions of Highmark, its subsidiaries or affiliates. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Highmark is a registered mark of Highmark Inc. © 2020 Highmark Inc., All Rights Reserved. Highmark Blue Cross Blue Shield serves the 29 counties of western Pennsylvania and 13 counties of northeastern Pennsylvania. Highmark Blue Shield serves the 21 counties of central Pennsylvania and also provides services in conjunction with a separate health plan in southeastern Pennsylvania. Highmark Blue Cross Blue Shield West Virginia serves the state of West Virginia plus Washington County. Highmark Blue Cross Blue Shield Delaware serves the state of Delaware. Each of these companies is an independent licensee of the Blue Cross Blue Shield Association. Blue Cross, Blue Shield and the Blue Cross and Blue Shield symbols are registered marks of the Blue Cross Blue Shield Association, an association of independent Blue Cross and Blue Shield companies.

Dr. Melissa Clarke, Senior Medical Director of Healthcare Transformation and Health Equity at 3M Health Information Systems, discusses the importance of addressing social factors to improve health outcomes and why data collection is crucial in addressing these Social Determinants of Health (SDoH).

A major driver of health disparities is that the system does not typically account for the differences in the culture, language, and experience of the patients it is charged to serve. Today we talk with Abner Mason, Founder, and CEO of ConsejoSano about the importance of customizing engagement to match the multicultural realities of your patients. Abner tells us that it's not about translating, but “creating content based on culture; based on deeper factors than language”. And it's effective. ConsejoSano is helping payers and providers get their patients into clinics and closing gaps in care. This of course leads to better outcomes, lower costs, and increased revenue for practices.   Key topics include:   What does it mean to create a more equitable and just healthcare system? How has COVID shone the light on the problems in our system? How do the Social Determinants of Health (SDOH) factor into health equity? Is there a willingness for providers and health plans to invest in these solutions? What did the original vision for ConsejoSano look like and how did healthcare's challenging reimbursement models lead to a pivot? How do you align patient engagement efforts with the multicultural reality of the U.S. population? How does your solution fit into the business model of providers and payers? What are the opportunities in Medicaid? Medicare Advantage? How are value-based payment models driving this work? What data is needed to support multicultural patient engagement? What is Health Tech 4 Medicaid and how is it enabling innovation in Medicaid? ConsejoSano's podcast: Health Equity Now     Abner Mason, Founder and CEO, ConsejoSano   Abner Mason is a healthcare technology leader who's dedicated to creating a more just, equitable, and effective healthcare system. As the founder and CEO of ConsejoSano, a multicultural patient engagement company, he leads a team of diverse professionals who strive every day to improve outcomes and lower costs on behalf of health plans. He's also the founder and chair of HealthTech 4 Medicaid, a nonprofit composed of innovative leaders working to radically change the pace of innovation to improve care quality and access. A federal and state government policy veteran with deep experience fighting the HIV/AIDS crisis, Abner knows how to tap people's unique talents and innate sense of compassion to achieve big goals.   ConsejoSano   ConsejoSano is a patient engagement platform that helps connect payers, providers and health systems with their multicultural Medicaid and Medicare patient populations. The company utilizes multi-channel engagement tools to reach patients in a culturally relevant way that increases engagement, lowers costs, and improves health outcomes. For more information, visit www.consejosano.com.   Connect with Abner on Twitter and LinkedIn Check out ConsejoSano and connect with them on Twitter and LinkedIn Watch the latest episodes of Health Equity Now, the show that's dedicated to spotlighting and solving health disparities, here   The #HCBiz Show! is produced by Glide Health IT, LLC in partnership with Netspective Media.   Music by StudioEtar

The PATHPod gals are back in the Bay Area for a delightful conversation with Dr. Kyra Bobinet, an expert in the areas of Social Determinants of Health (SDOH), learned helplessness and the iterative mindset. Kyra shares her personal story that lead her to go deep into SDOH and her desire to illicit engagement in whole populations. She does this by way of combining her backgrounds in neuroscience & public health to increase awareness around SDOH and the effect it has on all of us. Her unique perspective on behavior change, incorporating the ideas of learned helplessness and iteration will get you thinking, for sure. It certainly got Toni and Jenny’s wheels spinning! To learn more about how she uses these concepts to help others change their behavior, check out her work at freshtri.com or on Insta at fresh_tri. To understand more about this amazing human who is changing the world, visit her website at drkyrabobinet.com.

The pandemic has illustrated how Social Determinants of Health (SDOH) can impact the spread of disease, access to vaccines and the levels of trust in and utilization of basic health services. Beyond the focus on SDOH by politicians, advocacy, groups, and charitable organizations, there are private and public commercial organizations that make it a priority to find and fund solutions that address the social and cultural barriers that reduce or limit access to care. One of those organizations is Bayer. In this conversation with Dominick Kennerson, Global Head of Bayer G4A, we discuss how equity, access and sustainability help set the course for their investment strategy. This Coffee Talk is created in partnership with our Sponsor, Bayer G4A. This year Bayer G4A is looking for companies creating solutions to 5 key challenges including oncology, radiology, mental health, women's health and cardio metabolic and renal diseases.   The Bayer G4A program is open to companies from pre-seed stage to Series A, and even more advanced companies with traction in the market. Apply to be a part of Bayer G4A here, and tell them you heard about it on Digital Health Today. The deadline to apply is June 20, 2021. Guest Links and Resources: Connect with Dom Kennerson: Twitter | LinkedIn Connect with Bayer G4A: Website | Twitter | LinkedIn | YouTube World Health Organization - Website | Constitution Host Links Connect with Dan: Twitter | Linkedin Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram

In this Social Determinants of Health (SDOH) episode, Dr. Randy Vince (University of Michigan) moderates a talk with Dr. Robert Winn (VCU Massey Cancer Center) and technology innovator and cancer survivor, Sylvie Leotin (Equify Health) on solutions for rebuilding patient-provider trust and communications, with insights from the clinician and patient perspective. Subscribe: Apple Podcasts, Google Podcasts | Additional resources: elearning.asco.org | Contact Us Air Date: 6/9/2021

John Schwartz is Chief Revenue Officer at HSBlox and he strongly believes that care coordination is essential for all patients. The challenge is how can healthcare stakeholders improve the delivery of Social Determinants of Health (SDOH) to better serve vulnerable people.  Aligning medical and social care needs is a messy issue and there needs to be a stronger recognition of how much the environment determines health of a population. HSBlox enables SDOH risk-stratification, care coordination and appropriate data sharing through its digital health platform.  It applies AI, machine learning and blockchain technologies to streamline SDOH processes of data exchange, patient consent management and referral optimization. @blox_hs #HSBlox #VBC #AI #valuebasedcare #healthcareAI #healthcaredata #patientadherence #SDOH #socialdeterminantsofhealth #populationhealth #precisionhealth #DistributedLedgerTechnology HSBlox.com Listen to the podcast here

John Schwartz is Chief Revenue Officer at HSBlox and he strongly believes that care coordination is essential for all patients. The challenge is how can healthcare stakeholders improve the delivery of Social Determinants of Health (SDOH) to better serve vulnerable people.  Aligning medical and social care needs is a messy issue and there needs to be a stronger recognition of how much the environment determines health of a population. HSBlox enables SDOH risk-stratification, care coordination and appropriate data sharing through its digital health platform.  It applies AI, machine learning and blockchain technologies to streamline SDOH processes of data exchange, patient consent management and referral optimization. @blox_hs #HSBlox #VBC #AI #valuebasedcare #healthcareAI #healthcaredata #patientadherence #SDOH #socialdeterminantsofhealth #populationhealth #precisionhealth #DistributedLedgerTechnology HSBlox.com Download the transcript here

Vibhuti Arya, PharmD, MPH, Curating Brave Spaces, Global Lead, Equity Workforce Development, International Pharmaceutical Federation (FIP), Professor at St. John's University, returns to the Quality Corner Show to talk more Social Determinants of Health (SDOH) with PQS Senior Manager of Pharmacy Accounts, Nick Dorich, PharmD.In this episode, Arya talks about the importance of improving data and storytelling for SDOH.

For more information on this topic and to access resources mentioned, please visit metastar.com/podcast.

Conducting a Social Determinants Of Health (SDOH) assessment is very important to improve patient and population health. In this episode, NCHPH collaborated with La Maestra Community Health Centers to discuss screening tools to assess SDOH.

Direct Contracting is a new model from the Center for Medicare & Medicaid Innovation (CMMI, or the CMS Innovation Center) aimed at reducing expenditures and preserving or enhancing quality of care for beneficiaries in Medicare fee-for-service (FFS). At a minimum, it's an opportunity for providers to change the way they care for Medicare FFS patients. And if the Geographic Direct Contracting Model is launched (it's currently under review by CMS), it will be a sea change in the 10 targeted “Geo” regions. Either way, it's worth paying attention to. We covered the Direct Contracting model and options at length in Episode 156 with Gail Zahtz. You should start there if Direct Contracting is new to you. During that conversation, Zahtz identified plenty of areas where the model could benefit doctors and their patients. However, she identified several grey areas that make it difficult for physicians to engage with potential DCEs as the application deadline rapidly approaches (April 1, 2021). The timeline and lack of clarity make it difficult for a physician to evaluate the model and make a sound decision on how, or if to participate. So, that's our goal of this discussion.  I talk with Dr. Krishnan Narasimhan, an academic family medicine physician and an Associate Professor in the Department of Community and Family Medicine at Howard University, about what Direct Contracting means to physicians.   What opportunities does Direct Contracting create for physicians? What opportunities does Direct Contracting create for their patients? How does Direct Contracting compare to other value-based payment programs? How might Direct Contracting lead to deeper physician-payer alignment? How does Direct Contracting enable physicians to truly address the Social Determinants of Health (SDOH)? What questions should a physician ask a DCE to determine if they are a fit? What should physicians' do right now to determine if Direct Contracting is worth pursuing? How can busy physicians fit this in with all their existing priorities during a pandemic?   Dr. Krishnan Narasimhan Krishnan Narasimhan M.D., is an academic family physician who has a proven record of driving health system and policy change. Dr. Narasimhan has led grassroots coalitions to move the political and policy debate on health reform, expand access, and to increase primary care infrastructure. He has spoken at the U.S. Capitol, at universities, and with numerous stakeholders on health reform, health disparities, and physician workforce. He serves on the Boards of Doctors for America and the District of Columbia Academy of Family Physicians. Dr. Narasimhan has a decade of experience in undergraduate and graduate medical education with a focus on curricular design, mentorship, and integrated care models. He has a record of consistently increasing primary care workforce capacity. His research on the Economic Impact of Family Physicians has been utilized extensively by the American Academy of Family Physicians. Currently he serves as Associate Professor at Howard University, Director of the Family Medicine Clerkship, as Residency faculty, and takes care of underserved populations. His training includes an M.D. from Jefferson Medical College, residency at University of Connecticut, Primary Care Health Policy Fellowship at Georgetown University, and a Certificate of Health Policy at the Georgetown Public Policy Institute. Dr. Narasimhan is also an advisor to WiseCare, a startup applying to become a Direct Contracting Entity (DCE).  LinkedIn: https://www.linkedin.com/in/krishnanmd/   Links and Resources   Doctors for America - Doctors for America mobilizes doctors and medical students to be leaders in putting patients over politics on the pressing issues of the day to improve the health of our patients, communities, and nation. District of Columbia Academy of Family Physicians: The District of Columbia Academy of Family Physicians (DCAFP) is a state chapter of the American Academy of Family Physicians. A membership organization for DC Family Physicians, the Academy advocates for Family Physicians and our patients, and conducts continuing medical education for Family Physicians. Episode 156: Direct Contracting: It's Coming Fast and Will Have a Big Impact on Medicare-fee-for-service w/ Gail Zahtz – you'll find additional Direct Contracting resources there. WiseCare     The #HCBiz Show! is produced by Glide Health IT, LLC in partnership with Netspective Media.

In this episode of ASCO eLearning's Social Determinants of Health (SDOH) series, Dr. Hala Borno (University of California San Francisco) moderates a discussion with Dr. Fumiko Chino (Memorial Sloan Kettering Cancer Center) on understanding the cost of care and ways care providers can help patients and caregivers mitigate financial toxicity. Subscribe: Apple Podcasts | Additional resources: elearning.asco.org | Contact Us

In this episode of ASCO eLearning's Social Determinants of Health (SDOH) series, Dr. Jacquelyne Gaddy (University of North Carolina Chapel Hill) moderates a discussion with Dr. Reginald Tucker-Seeley (University of Southern California) and Dr. Katie Reeder-Hayes (University of North Carolina Chapel Hill) on how to take a social history, with a focus on cultural humility and addressing implicit bias. Read more about this topic in Dr. Gaddy’s recent ASCO Connection article. Subscribe: Apple Podcasts | Additional resources: elearning.asco.org | Contact Us

Local health departments are increasingly recognizing that we must look not only at health outcomes, but at the root causes of poor health by understanding the social and physical conditions in which people live as measures of community health. These conditions affect health and well-being broadly, predisposing some communities to better health and placing obstacles to health for others through unequal distribution of these conditions. Healthy People 2020 Social Determinants of Health (SDOH) describes characteristics of places that can impact health such as “the resources and supports available in our homes, neighborhoods, and communities; the quality of our schooling; the safety of our workplaces; the cleanliness of our water, food, and air; and the nature of our social interactions and relationships.”

In this episode of ASCO eLearning's Social Determinants of Health (SDOH) series, Narjust Duma, MD, moderates a discussion with ASCO CEO, Clifford A. Hudis, MD, FACP, FASCO and Sybil R. Green, JD, RPh, MHA, Director of Strategic Initiatives in ASCO’s Policy and Advocacy Department, on what ASCO is doing as a professional society to address equity as part of its mission.  Subscribe: Apple Podcasts, Google Play | Additional resources: elearning.asco.org | Contact Us   Transcript: PRESENTER: The purpose of this podcast is to educate and inform. This is not a substitute for medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. NARJUST DUMA: Welcome, everybody, to the second episode of ASCO's Social Determinants of Health series. My name is Dr. Narjust Duma. I am an assistant professor at the University of Wisconsin and also a thoracic oncologist. Today I'm joined by ASCO's CEO, Dr. Cliff Hudis, and Sybil Green, Director of Strategic Initiatives in the policy and advocacy department for ASCO. This series is a new initiative proposed by ASCO president, Dr. Lori Pierce. It focuses on increasing oncologists' awareness about the social determinants of health through the cancer care and how impacts our patients' outcome, including modifiable risk factors. This series is inspired by Dr. Pierce's presidential team of equity, every day, every patient, everywhere. In this episode, we look at what ASCO is doing as a professional society to improve health equity and cancer care. Welcome, Dr. Hudis. Welcome, Mrs. Green. First I would like to us what is ASCO doing as an organization in the matter of health equity and cancer care? CLIFF HUDIS: So I guess I'll start here. Thank you very much for spending some time with us on this. If you look at ASCO's mission, it is conquering cancer through research, education, and the promotion of the highest quality and equitable cancer care. So the idea of equity and our responsibility to address disparities is really in our organizational DNA. I have to point out something that many people may not realize. But when ASCO was founded in 1964, one of the seven founders was a black woman, Jane C. Wright. Dr. Wright died in February of 2013. But her father was among the first African-American graduates of the Harvard Medical School. His father was also a physician. And he was educated at what became Meharry. So I remind everybody of this as often as I can, to make the point that not only do we have an opportunity to advance equity and to deal with disparities in health care, but it's my perspective as a leader of ASCO that we have a special obligation and responsibility to do all of that. So we can talk more about it. But I'll just introduce maybe the answer by saying there are really two broad themes at work for us at ASCO. One is externally facing. And one is internally facing. The externally-facing work includes a range of projects and output that we can talk about a little more, but for example our position papers describing disparities and then identifying potential steps to take to address and solve them. But it also includes support for targeted research that is meant to narrow those gaps. It includes our educational efforts, both for our members and for legislators, advocacy for policy, and so on. And then on the internal side-- and here I'll ask Sybil to talk a little bit-- I think we've recently recognized our opportunity, and again responsibility, to think about the workplace itself and to think about our staff and to think about the activities and actions we can take and the roles we can model to create a better world. So I know I've been high level in my initial answer here. But the two domains again are external and internal. And then we can talk about some of the specific projects as we go on. NARJUST DUMA: Mrs. Green, I think it's very important to share about these internal aspects of ASCO because many of us are now aware as members, we see the surface. But ASCO is a large organization with many staff and members. So it would be great that you can share that with us. SYBIL GREEN: Absolutely. And thank you for allowing us to share that. I think Dr. Hudis pointed out some of what we've done since ASCO's establishments and really charging everyone on staff to really live out that obligation of equity, diversity, and inclusion. And so through our programs, our staff have to do their work, make sure that we are creating equitable opportunities for patients and physicians, but it starts at home. And so we have to make sure that internally, we are offering those same opportunities for our staff to engage because what we know is that when staff are engaged, and they have the opportunity to bring their true selves to work every day, they bring their personalities. They bring their lived experiences. And that all plays out in the work that we're doing on behalf of members, in their patients, but also for staff. I think if I were sum up where our program is going, similar to what Dr. Hudis has done, the three components are really enabling staff success. We ought to be able to do that for our staff internally. Every day we ought to provide opportunities for them to succeed. And then making sure that our partnerships-- those that we work with, whether it's in our publications, our meetings-- making sure that our partners goals and ideals align with ASCO's values and ideals. And all of this, of course, is in support of the greater ASCO enterprise, which is our members and the patients and of course, ASCO staff. NARJUST DUMA: And I think that it's really important-- I had the pleasure of interacting with several staff members with diverse backgrounds. And I think as we develop the mentorship program and other things, their input is diverse. It means we also are able to cover the trainees needs because every trainee's needs are different. And because I cannot give a talk or do a podcast without mentioning my grandma, [INAUDIBLE], I have to say that it's important to clean your house first before you go and try to clean other people's houses. I do promise it's beautiful in a Spanish. But I think it's important that everybody knows that internally ASCO is doing a lot of work. And I think it's important to talk about the grants in health equity. And I'm mentioning this because I haven't been doing health equity since I was a med student. And sometimes you find yourself not having enough grant opportunities. Now there is an increase. But when you compare it to other areas of oncology, you may be more competitive because there are less grants. And I think it would be great to hear from the both of you about the new health equity grants, the breast cancer disparity grant, and beyond. CLIFF HUDIS: Well I would just point out something to build on your comment, first of all. Since we were founded in 1964 til now-- so just over 55 years-- we've made unbelievable advances, I think, in oncology in general. Indeed the reason I as an old man chose to go into an oncology in the 1970s was that the vision ahead was that this was going to be an exciting field. And it has not disappointed. However there's a dark that I think we should acknowledge. The advances have not been fairly or evenly distributed. And indeed in some cases when we make massive improvements in outcomes in terms of what's possible with state-of-the-art care, we increase disparities because not every group catches up. And I say all that because it's important to understand that this is not about abstraction. These grants that address that gap are as or more important than the basic science grants that actually advance the biology and understanding in the first place. One without the other is incomplete. So I can't agree more that this is important. And actually from an investment or return on investment point of view, in some ways, these grants are an even better deal because we can rest many of these gaps in care delivery and in knowledge pretty quickly and narrow the gap. And we've seen it. I'm going to give you some examples in a moment. Whereas funding basic science, honestly, is a much higher risk proposition, if you think about it. So I don't mean to set up a false competition here. But I want to point out that there's a big reward. So here's an example. The plenary session abstract at ASCO two years ago now-- abstract number one, if you recall, was no moral less than an analysis of the impact of Medicaid expansion. And what did it show? It showed that with Medicaid expansion, those states that implemented it quickly narrowed the gap in time to initiation of therapy for curable colon cancer. It's a simple take-home point. I care passionately about this personally because these are differences in outcome that have been labeled as associated with race for many years or other specific ethnic facts. But really what they're about is nothing except unfair, uneven access to care in the first place on the basis of race. And it's something that we can address. So we are building out programs to address this through a number of granting mechanisms. For 2020 alone, there are going to be two Young investigator awards that are earmarked for underrepresented populations. And there's a career development award and another YIA, Young Investigator Award, in health disparities specifically. But this is just, I think, part of the issue. The other issue for us-- and actually a commitment going back for years-- is to do something about the workforce itself. And I don't have to tell you, but of course, there is a huge disparity playing out when we look at makeup of medical students in America. And it gets accentuated to the extreme when we look at black men. They are the most disproportionately underrepresented group right now. So how are we going to address that? And we're really proud this year to be launching a program that is aimed at newly-matriculating medical students building on a successful program in Boston that's been running for a couple of years already with Bob Mayer is the founder. And our goal is to the interest of specifically targeted populations, not just in medicine but specifically in oncology. NARJUST DUMA: Mrs. Green, you would like to add something about the grant and what is happening to support health disparities various research at ASCO? SYBIL GREEN: I'll just add the importance of any grant opportunity in any program being one to two. So it's one thing to be able to address bringing in the right medical students to be able to mirror the populations that they serve. It's something else to continue to support them along the way, and so not just stopping at the students, not just stopping at the research, but also making sure that was they're in practice they're supported. And a couple of grants that we've had for some time focus on quality, not just in ensuring that quality services are delivered, but actually helping practices to determine how to identify gaps in [INAUDIBLE] populations that are underserved because we may not be able to identify those same gaps that we would identify in majority populations. And so by giving them the tools to some of the other programs that ASCO has to be able to identify those gaps and then to support them along the way is really important. NARJUST DUMA: And I want to add to what Dr. Hudis mentioned about workforce diversity because this is one of my areas of research and passion. And it's extremely important to have a diverse workforce to represent the patients we're caring for. It's not only having a diverse workforce, but having a workforce that practices cultural humility. We cannot assume that we are proficient or we are competent in somebody's culture. I'm a Latina. And there are so many Latinos in so many different backgrounds that I cannot learn them all. And I think it's important that early interventions are-- because when you get exposed to a specialty early on during the training, that would change your pathway. I'm the daughter of two surgeons. I'm supposed to be a plastic surgeon. But a patient with cancer changed my life and my pathway. So we're able to support those students that have less resources and less access-- and that also includes rural students-- they may don't be black or Latino, they may be white, but they come from rural areas with limited resources-- we are sure that we meet the patient needs because there are aspects I don't understand. Like I'm in Wisconsin, and there are some aspects to farming I didn't know. Now I know when harvest is. And all of that allows us to plan appropriately. So I can see how important it is. And there's a task force that is run by Dr. Winfield, which I'm lucky to be part, that focuses on the workforce diversity. Along those lines, as a minority in medicine, I have seen up and downs of the interest in workforce diversity and health equity. I think many events in 2020 helped a lot of people open their eyes or be more conscious like, oh, that's not isolated. That happens in my back yard. It happened in Kenosha, Wisconsin. But we want to hear how is ASCO making these things long term, how the internal and external changes are going to be long term? And I will start with Mrs. Green and then go to Dr. Hudis. SYBIL GREEN: So in terms of making it long term, it can't be one and done. I think quite often when we focus on equity and diversity issues, we always look at diversity first. And so whether it's workforce or whether it's increasing opportunities for access, you can't just look at the numbers. You have to also think a little bit deeper. You have to think about culture. And so culture with humility, like you mentioned, Dr. Duma, is important, but making sure that attitudes are changing along the way. And that happens through self-awareness. That happens through understanding. And I think that ASCO plays a real role in making sure that our members understand what the issues are and how to dig past those things and provide them with the tools to be able to [INAUDIBLE]. ASCO I think, is not unique. And the idea that this is all new to us has gotten a lot of attention because of some of the social and racial injustice. But what that means is that our members now are probably more interested in ensuring equity than ever before. But we have to teach them how to do it. We have to teach them how to speak the language. We have to teach them how to be more aware, both in their own organizations, at ASCO internally, and for their patients. And so it's a cultural change. It's not going to happen overnight. It's gradual understanding of the dynamics, gradual understanding of different peoples goals, and meeting them where they are, so that we can help them to move along, so that we can come to a more equitable and just [INAUDIBLE]. CLIFF HUDIS: I think one of the things Sybil and I spoke about this summer is we launched our internal EDI effort-- relates to this. And that is this is not about identifying a leaky pipe and patching it and saying, well, we're done now. This is actually, in my view, a permanent change in the way we see work and the way we see our growth. So the goal is to reach a specific landmark. The goal is to change how we think about our work and how we think about our role in the world, so that we're constantly improving. And it's a journey, not a destination, I think, which sounds trite. But that's the spirit of it. And it gets to your question about how we make sure that the commitment is continuous and not just while it's [INAUDIBLE] and exciting. And I think we are committed and dedicated to that. I do want to present a related challenge because it's something you said really sparked this thought for me. As a physician, when did you know that you wanted to be a physician? How old were you? NARJUST DUMA: I was 5. CLIFF HUDIS: And, Sybil, when did you know what your career path was going to be? SYBIL GREEN: I was 9. CLIFF HUDIS: That doesn't support my thesis [LAUGHS] [INAUDIBLE]. So here's the issue. The issue of burnout in medicine right now is getting a lot of attention. And one of the reasons for it, frequently given, is that doctors on average decide to commit to their careers a decade younger than most people on average commit to other careers. You're an exception, Sybil, so I should have pretested the question. But the issue is we're not here to talk about burnout today, even though that's really important. The issue is this. In order to ultimately address the makeup of the population of physicians, we need to reach deeper and further into precollege communities. And we need to show people that they could have lives in science and health care and in medicine and maybe specifically oncology. And I'm just pointing out to you that that's a daunting challenge for a professional society like ASCO. That's not our audience. We don't have a natural connection there. And one of the things that we're working on right now is identifying programs that have worked, that exposed high school students from previously excluded populations or communities to medicine, so that we can spark that passion before college, not during college, and therefore have the commitment that it takes to go far into medicine. And I'll just close by saying something that you hinted at but needs to be said. The reason to have diversity in our workforce is not that an Asian patient needs an Asian doctor. It's that an Asian patient needs a practice that has Asian doctors in it, so that the practice as a whole is able to be culturally sensitive and able to relate and communicate and support them because I think sometimes this issue gets oversimplified as well. SYBIL GREEN: So Dr. Hudis, your theory is not completely [INAUDIBLE] I think it's relevant to this conversation because while I knew what I wanted to do at 9, what I didn't have was the representatives in the community. I didn't have the mentor. Interestingly enough, I had more mentors in pharmacy than I had in law because I saw pharmacists who looked like me. I happened to live in a town where there was a historically black college with [INAUDIBLE]. And so I saw people look like me. And it made it a lot easier for me to reach out to them, for them to mentor me, for them to start talking to me about what equity in health care looked like. That really wasn't until I was in college. But the truth of the matter is for most diverse students, most minority students, that doesn't exist. And I think that that's where ASCO's mentoring programs are really rich. You have the opportunity to do that. NARJUST DUMA: And I think this is important because you can do what you can see. And that has been proven over and over again. We unfortunately are running out of time. But I want to ask the final question. Like a manuscript, like a study, everything has limitations. And I think it's important that we talk about the limitations of ASCO doing this work because realistic expectations are helpful so we don't get disappointed when we have big expectations that may not be met. So Dr. Hudis, what are some of the limitations of ASCO to help equity work now? CLIFF HUDIS: You're right, it's a huge issue. If you think about where our scientific focus is, we can measure the disparities or the difference in outcomes. And we can write a paper about that but when you really get to addressing the reasons for it, it extends far beyond what we can do. So I guess our limit is we can call attention and rally colleagues and collaborate across the House of Medicine and broadly into Congress, where we can make a difference-- or to the United Nations and World Health Organization. But we can't do this heavy lift alone. We need other colleagues who agree who are willing to invest time and money to make the change. SYBIL GREEN: And I would add partnerships because as much as we're talking about social determinants of health, we recognize that all social determinants of health are not health related. They're not [INAUDIBLE]. And many of them live and operate outside of the realm of health care. But what we can do is bring our expertise to the table about the impact of those things, so that our partners stand in their own world, in education, in criminal justice, in financial assistance, how that can help really change the outcomes for patients. I think at ASCO, we've got that expertise. And we can do that. NARJUST DUMA: Thank both of you for your time. Thank you, everybody, for joining us for the second episode of ASCO Social Determinants of Health series. Please keep up with us. You can subscribe. You can see this on Facebook, YouTube-- when it becomes available. We'll continue to explore the social determinants of health and cancer care. You can leave feedback or emails, any questions to the professional development, at asco.org. And I thank you for your time. And have a wonderful week. PRESENTER: Thank you for listening to this week's episode of the ASCO eLearning weekly podcast. To make us part of your weekly routine, click Subscribe. Let us know what you think by leaving a review. For more information, visit the comprehensive eLearning center at elearning.asco.org.

The COVID-19 pandemic has shone a new light on the deep-rooted disparities and inequities that are built into the fabric of our American healthcare system. Triggered in part by the pandemic, as well as a number of deeply disturbing episodes of racist police brutality, and the Black Lives Matter movement, we’re experiencing a national re-awakening of concern regarding systemic and institutional racism in our society.Our two distinguished guests in this interview, Dr. Alisahah Cole and Michellene Davis, are nationally recognized leaders in the movement to eliminate healthcare disparities. Michellene Davis, Esq. is currently the Executive Vice President and Chief Corporate Affairs Officer at RWJBarnabas Health, the largest academic healthcare system in New Jersey. She is an attorney and has held positions at the senior most tier of government, including as State Treasurer, Chief Policy Counsel to a Governor, and CEO of a state lottery. Dr. Alisahah Cole is currently the System Vice President of Population Health & Policy at CommonSpirit Health, one of the largest integrated healthcare systems in the United States. She is a Family Medicine physician and has held multiple leadership positions including as Chief Community Impact Officer and Academic Chair, implementing novel approaches to improve health equity in vulnerable populations.This interview was recorded last month as a panel discussion during a virtual conference on patient experience. The topic was originally intended to be a discussion on the Social Determinants of Health (SDOH). But we felt that it would be culturally tone-deaf and socially irresponsible to discuss the SDOH without recognizing systemic and institutional racism as a root cause of the inequities and disparities in health care delivery and health outcomes.With that in mind, this panel discussion includes:A passionate discussion on this most recent ‘awakening of awareness’ about the systemic & institutional racism in our society - including the impact of the COVID-19 pandemic.The manifestations of systemic, institutional & interpersonal racism in healthcare.Practical, real-life recommendations regarding a systematic, data-driven approach to identify, understand & eliminate racism in healthcare.In addition to bringing their experience as clinicians and executives, Michellene and Alisahah also share their lived experience as professional Black women. The stories they share are honest, courageous, and at times, unsettling. For example, Michellene shares that, unlike her white colleagues, she does not have the luxury of putting racism aside, even for a moment. Alisahah shares that, as the mother of two teenage Black boys, she worries for their lives, literally, each time they leave home to venture outside.  This conversation challenges the very core of our humanity - in our communities, our corporations, our social institutions and our government. One lesson this interview taught me is that the issue of ‘social determinants of health’ needs to be reframed in terms of eliminating the racial disparities and inequities in healthcare and in our broader society. Another is that good intention is not enough - we need to take sustained systemic action.There are so many lessons embedded in this podcast. Lessons about listening and building trust. Lessons about the unhealthful effects of racism on Americans of color. Lessons about the need to fundamentally reorient, redesign, reorganize and appropriately resource healthcare delivery so that it meets the needs of vulnerable populations. And lessons about the need to expand healthcare delivery beyond traditional medical boundaries - to apply a racial equity lens to how we reframe our education system, our criminal justice system, our housing and urban development system, our transportation system, our social services systems, our labor system, and our public health system.This was the most important interview I've conducted to date. I say that with Martin Luther King’s words ringing in my ears. Words that, sadly enough, have as much relevance today as they did when he delivered them over five decades ago, during a 1966 speech before the 2nd National Convention of the Medical Committee for Human Rights.  Of all the forms of inequality, injustice in health is the most shocking and the most inhuman because it often results in physical death. I see no alternative to direct action and creative nonviolence to raise the conscience of the nation.Martin Luther KingUntil Next Time, Be Well Zeev 

In ASCO eLearning’s first Social Determinants of Health (SDOH) series episode, Dr. Ramy Sedhom, MD moderates a discussion with ASCO President, Lori Pierce, MD, FASTRO, FASCO; Abenaa Brewster, MD, MHS; and Katie Reeder-Hayes, MD, MBA, MS on why understanding SDOH’s impact on patients is critical to providing equitable care. We hope you enjoy this episode. Subscribe: Apple Podcasts, Google Play | Additional resources: elearning.asco.org | Contact Us ANNOUNCER: The purpose of this podcast is to educate and inform. This is not a substitute for medical care, and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. RAMY SEDHOM: Hello, and welcome to ASCO's newest podcast focused on the social determinants of health. My name is Ramy Sedhom, and I'm a medical oncology fellow at Johns Hopkins. Today, I am joined by ASCO president Dr. Lori Pierce, professor of radiation oncology at the University of Michigan. We are also joined by Dr. Katherine Reeder-Hayes, associate professor of oncology and health services researcher from UNC Chapel Hill, also chair of the ASCO Health Equity Committee. And finally, we are also joined by Dr. Abenaa Brewster, chair of the ASCO Prevention Committee, medical oncologist, and professor of epidemiology at MD Anderson. All our distinguished health researchers focused on disparities work. We are excited to launch this theme in light of the theme as highlighted by Dr. Pierce, equity, every patient, every day, everywhere. Dr. Pierce, why are the social determinants of health relevant? How do they relate to our work at ASCO and to the theme of equity? LORI PIERCE: Thanks, Dr. Sedhom. Yes, the ASCO theme this year is based on equity, and treating patients with equitable care is at the very heart of what ASCO does. It's what ASCO stands for. But we know there are factors, including social determinants of health, that can significantly affect the quality of health care that our patients receive, so we're hoping that this series of talks will increase awareness to many of those factors so providers can understand even better what some of the barriers are that our patients are experiencing. So we feel that understanding what they are, that's an important first step in terms of determining meaningful actions that we can take. RAMY SEDHOM: Thank you, Dr. Pierce. Dr. Reeder-Hayes, any additional comments? KATHERINE REEDER-HAYES: So I would just add that the reason I think oncologists inherently do care about the social determinants of health is that we care who gets cancer, and we care about the survival of that cancer. That's what we do as physicians. And as we follow cancer outcomes and cancer registries over time, what we realized is that there are a lot of biological things about cancers that determine their outcomes, but there are also many things that determine that outcome of a person's cancer that aren't biologic, and we have put those things together in a large group and use labels like the social determinants of health to understand what those non-biological factors are. But as physicians, as people who want to cure cancer, I think that it's just as important for us to have a good understanding of those non-biologic factors and how they're going to influence our patient's chance of the best outcome from their disease as it is for us to have a good grasp on the biologic determinants that are going to influence our patient's outcome. RAMY SEDHOM: Thank you. And I think this is a really good time to emphasize that the series is at the intersection of work through the Health Equity Committee and the Prevention Committee as being put forth by ASCO, and the ASCO Education Committee as well. And Dr. Reeder-Hayes, how would you importantly define the social determinants of health? KATHERINE REEDER-HAYES: So that's a pretty broad range of definitions, because there are a lot of people in health care who have talked about this concept of non-biologic determinants of how patients do for a long time, both in cancer care, and in other fields, like primary care, diabetes, and hypertension research. And so there are several organizations that have put forth definitions. The first one that I would point people to as the World Health Organization. So these patterns occur globally, not just in the United States. And the WHO describes the social determinants of health as the circumstances in which people are born, grow up, live, work, and age, and the systems that are put in place to deal with illness. So there's this idea that the circumstances that people find themselves in, as well as the structure of the health care system are part of this conversation about social determinants of health. The Robert Wood Johnson Foundation has done a lot of work to help put these concepts into more understandable and everyday language. And so the definition they use is that health begins where we live, learn, work, and play. So the social determinants of health include factors that operate on a few different levels. So there's the level of societal conditions, social conditions, economic conditions, physical conditions of where and how people live, and where and how people work, and then there are also psychosocial levels, like the patient-level psychosocial factors. And Centers for Disease Control also focus a lot of their work on social determinants at this idea of psychosocial factors at the patient level. So even though the concept is simple, it's actually also very broad. And when people talk about social determinants of health, they can be talking about things that are operating at several different levels, from the structure of the health care system, on down to the structure of the apartment complex where your patient lives. And so you have to think broadly, I think, when you're thinking about analyses for research or how to talk to your patients about social determinants of health. But the American Cancer Society has recently also put out a paper that tried to help people put these social determinants into appropriate buckets, particularly the ones that really seem to impact cancer care. And so the three categories or domains that they've suggested are structural inequities, so things that happen in a larger society and in the structure of the health care system that impact our patients and how they access care. Secondly, institutional environments. What do the places where we treat cancer look like? What are their structures? And how does that impact our patients outcomes? And then, finally, living environments. Where do our patients go back to when they go away from the health care setting? So those are some of the ways that we can think about the finding and talking about the social determinants of health. RAMY SEDHOM: Thank you for sharing that. That's a lot to think about and to consider. Dr. Brewster can you comment on the impact of those social determinants of health in disparate groups beyond race and ethnicity? ABENAA BREWSTER: So I agree that we're really used to thinking about social determinants of health as explaining some of the race-ethnic disparities that we see in cancer incidence and outcome. But we know that there are other groups that also experience differences in outcomes based on these determinants. For example, characteristics of sex, gender identity, sexual orientation, geography, immigration status, these are all characteristics that are impacted by social determinants of health. An example that I like to give for the race-ethnic disparity is the 40% increase in mortality that African-American women experience who are diagnosed with breast cancer compared to white women, and that, for a large part, is due to socioeconomic poverty and insurance differences. And in fact, then those characteristics then explain decreased screening, later stage of diagnoses, and then leads to disparate delays and receipt of treatment. There was a really nice paper published in JCO by Jamal and others which showed that insurance alone accounted for about 37% of that 40% increase in mortality that Black women experience who are diagnosed with cancer. And so you can see the great opportunities that are there to make care more equal if you're able to improve access. And so examples of other groups, for example, we have registry data showing that urban populations, although they have higher cancer incidence, the rural populations actually have a higher incidence of the cancers that are related to tobacco use or HPV. And we also know that rural populations also have higher mortality than urban populations when it comes to cancer, and that's largely driven by poverty, under insurance, socioeconomic status, isolation. And so that's another group that is impacted by those social determinants of health as outlined by Dr. Reeder-Hayes. And then, lastly, the LGBT community. Although there haven't been a lot of large studies looking at the impact of cancer incidence and outcomes in that community, there have been lots of survey studies that have shown that these determinants of health tend to cluster within those communities. Once again, social isolation, negative patient-provider relationships, under insurance, poverty, and so that's another group where this becomes very meaningful. And I think kind of what cuts across all of these groups are really characteristics that have been linked to historical discrimination. And so that's something that we see very clearly. And then, we also see it reflected in our oncology population, right? Only about 2% of oncologists are African-American. And so these social determinants of health not only impact our patients, but they impact what our workforce looks like, and then, that, in turn, leads to differences in terms of the patient-provider relationships. RAMY SEDHOM: Absolutely. And this is a great question to direct towards you as the chair of the Prevention Committee. How do the social determinants of health-- how are they relevant for our cancer patients and our cancer survivors? ABENAA BREWSTER: Social determinants affect the trajectory of cancer care. And so we've talked about the impact of social determinants of health on cancer mortality and cancer outcomes, receipt of treatment, timing of treatment. So those are all impacts that our oncology patients face. But I would say, in terms of the field of cancer prevention, over the past four decades, there have been significant advances in cancer prevention, vaccine, preventive therapies, high-quality screening. And unfortunately, there are populations that are being left out of those advances that we've seen in cancer prevention. We also know that maintaining a healthy weight, having a physically active lifestyle, having a nutritious diet with fruits and vegetables also play a key role in cancer prevention. But those are impacted by where our patients live. And so patients who live in disadvantaged neighborhoods may have less availability for these nutritious food choices, and they may have less safe spaces to engage in physical activity. And so while we advance our prevention knowledge and our prevention strategies, we are leaving behind groups of individuals who, based on where they live, and where they work, and how they're educated, are not being able to access those types of advances in cancer prevention, and as a result, we see increasing cancer incidence. RAMY SEDHOM: And Dr. Pierce, how does having this context or understanding make us better researchers, clinicians, and administrators? And also, how does it benefit our interactions with our patients and our colleagues? LORI PIERCE: So understanding the social determinants of health, it will make us better researchers, then clinicians, and just better doctors, because it allow us to see how the cancer world looks to our patients, kind of look at the cancer world through their lens. And an example, we have all these groundbreaking therapies, but if the patients don't have transportation and they can't come in, then those therapies are for naught. And I'm going to echo what Dr. Brewster said a few minutes ago. Another example is if we're advocating for patients to maintain a healthy weight, and a part of that is to do exercise, but they can't go out in their communities because they're not in a safe community, then we need to come up with other strategies. So I think it's very important that we understand these issues so we can advise, we can advocate, and we can act once we truly understand the barriers that our patients are facing everyday. RAMY SEDHOM: And Dr. Reeder-Hayes, can you comment on how the Health Equity Committee is seeking to understand the social determinants of health, their effects on populations, and the actions that can be taken to improve cancer care? KATHERINE REEDER-HAYES: Sure, so one of the things that the Health Equity Committee has been really excited about and working with Dr. Pierce on, her presidential theme, and also, in entering this conversation about the social determinants of health, is getting more of our members engaged with the idea of knowing our patients and their non-biologic characteristics as a way of being better doctors, as Dr. Pierce said. So the most simple way I can explain the concept is that every patient has a backstory. We know this as doctors. Every patient brings this unique story into their cancer care experience. And we know intuitively that that story that they bring with them into cancer care is going to impact what their cancer journey looks like. But we also need to acknowledge that it's going to impact their cancer outcome. We already know that it's going to impact how we interact together as a team, patient and provider, but we need to raise awareness that it's also going to impact how the cancer turns out. Because I think that's something our members naturally care about, and I think our members want to understand their patients' cancer care stories, So as researchers, and as folks on the Health Equity Committee, we would like to help people understand how to obtain the most relevant information about their patient's backstory in the most respectful and efficient and effective way, and then to integrate that well into how they care for their patients, as well as how they shape their research and their administrative roles. So we're excited to be doing that. Now, some of these circumstances are not immediately changeable, and they certainly aren't within the patient's individual power to change, but some of them, at least in terms of how they impact our patient's access to care, are modifiable, either by us as their physician, or by someone else in the health care system, or by someone in an organization that comes alongside the health care system to help, like a private foundation or a philanthropic organization. If our patient has a barrier to care because of transportation, like the example that Dr. Pierce gave, and they can't get a ride to cancer care, there are actually some ways that we can intervene on that. And there are even people in our health care system who are expert on how to intervene on that, as well as organizations that have volunteers that can help intervene on that. But if we don't obtain the information, we're not going to know, and then we can't bring the strategy to bear to get our patient to that groundbreaking therapy that they get. If they could make it to us, or if we could make it out to them, thinking about innovative ways to deliver care. So those are some of the things that we're excited about in the Health Equity Committee. RAMY SEDHOM: Thank you for sharing with us a lot of the great work that you're doing, and the ASCO team. On a similar note, Dr. Brewster, can you review with us some of the key contributions related to the social determinants of health from the Prevention Committee? ABENAA BREWSTER: Sure. Well, first of all, I'm so proud of the ASCO Cancer Prevention Committee for the work that they've done over the years to raise awareness, not only about cancer prevention to the public, but also within the oncology community. And ASCO's Cancer Prevention Committee has really spearheaded ASCO's work in tobacco control and cessation over the past 20 years, including supportive position statements on tobacco cessation and control, and also, for the electronic nicotine delivery device systems. And the committee continues to educate providers on the importance of addressing smoking cessation among their patients before and after a diagnosis of cancer. Also, within the area of obesity and energy balance, the committee has issued a position statement, because, actually, the majority of Americans are not aware of the impact that obesity has on cancer risk and cancer prognosis, and just raising the awareness of that issue, particularly around underserved populations, is important, because those are the populations that actually have some of the higher rates, but also lack that knowledge. And so the committee has conducted surveys of not just oncologists, but also patients, to try to really understand how that information is being disseminated, and then what are the barriers to be able to address the issue of obesity? And so that's important work that's going on. And a few years ago, the Prevention Committee also issued a statement on the association between alcohol and cancer risk and outcomes, and that's kind of all still a risk factor that has very little public awareness of its importance, and that's really driven a lot of the media and other publications that have come out really showing that association. And so raising that awareness is important. And the good news is that there are strategies and interventions and policy changes that can be brought to bear to impact some of these modifiable risk factors. And so that's a very exciting avenue for research and practical applications. RAMY SEDHOM: Thank you, Dr. Brewster. That's actually a wonderful shift toward policy and advocacy. And I, myself, participated on the Hill with ASCO. And Dr. Pierce, can you share with us or discuss some of the advocacy efforts from ASCO for our patients and lawmakers who can help in critical ways as it relates to the social determinants of health? LORI PIERCE: Thanks for the question. It's a great question. Advocacy is so important. So important that we advocate for our patients, because they often can't advocate for themselves. And we advocate to lawmakers, that's on a local level, on state level, and a national level, because it really can highlight to our lawmakers some of the barriers that our patients face and things that they can do to remove those barriers. And I'll give you a great example, HR 913, the Clinical Treatment Act. For those of you who don't know what that is, it's the following. Medicaid is the only insurer that does not cover routine care costs for patients, Medicaid patients who go on clinical trials. They're the only insurer that doesn't do that. And you talk about routine costs, we're talking about doctor visits, we're talking about x-ray tests, routine blood tests. The irony is Medicaid will cover these same costs if patients were not on a clinical trial, but they won't cover it on a clinical trial. And of course, we know there are a lot of minority patients that are on Medicaid. And so this is the disincentive for minority patients to go on clinical trials, which is exactly what we do not want to see. And so ASCO has been spending quite a bit of time advocating to the legislation about how important it is to cover these costs in clinical trials. And so the House has legislation, and just last week, the Senate now has parallel legislation. So we are moving the needle. We are going in the right direction. And it's a very important example of just what advocacy can do in terms of improving care for our patients. RAMY SEDHOM: That's great to hear, and we hope things continue to move forward. Dr. Pierce, also would like to direct this question to you. What is your vision for the future of this podcast series? And what do we really want our listeners to take home from this? LORI PIERCE: So I'm so excited about this series, and I am so appreciative to everyone, those who are on the series, and everyone in the background for getting this going. It's my hope that the series of broadcasts will be an important educational tool to really understanding the social determinants of health and how they impact our patients and society at large. And so this series will contain a lot of aspects, a lot of podcasts and videos on social determinants of health that our task force, which you are a key member of, is helping us to design. So our task force is made up of fellows and junior faculty, the future leaders of ASCO, and the future leaders of oncology in general. So thanks to your enthusiasm, thanks to your feedback, we are launching this, and I am super, super excited. RAMY SEDHOM: Thank you, again, everybody. The conversations today are really a reminder of all of our shared experiences. I remember as an oncology fellow, oftentimes, the hardest part of care in the clinic was not the science or the biology of cancer, but actually, all of the things discussed today, especially the social determinants and how they impact our patients. Again, we want to thank all of our wonderful faculty for serving as change agents. The planning of this podcast series is a joint effort through all of the wonderful ASCO volunteers who are fellows, junior faculty, ASCO leadership, and importantly, cancer survivors and ASCO staff. We do want everyone to look forward to next month's episode, where we will discuss and look at what ASCO can do as a professional society to address equity as a part of its mission. Again, thank you to all of our listeners, both locally and abroad, for joining us for this episode of the ASCO podcast series on the social determinants of health. To keep up with the latest episodes, please be sure to subscribe. Let us know what you think about this series by leaving a review or by emailing us at professionaldevelopment@asco.org. Again, thank you, and we look forward to seeing you in the next episode. ANNOUNCER: Thank you for listening to this week's episode of the ASCO eLearning weekly podcast. To make us part of your weekly routine, click Subscribe. Let us know what you think by leaving a review. For more information, visit the Comprehensive eLearning Center at elearning.asco.org.

In this episode of the Avalere Health Essential Voice series focused on the Social Determinants of Health (SDOH), Avalere experts discuss strategies for SDOH solutions and how to incorporate them in the manufacturer space.

The Social Determinants of Health (SDOH) is a central dogma to the field of public health. There are many different definitions of SDOH from reputable organizations, however, in its simplest form, it refers to the social and economic conditions in which people are born, grow, work, live, and age - working as a system to influence the health of populations. Linda Holdbrook joins the Public Health Insight Podcast to discuss some of these SDOH as identified by the World Health Organization and the importance of incorporating these determinants to achieve effective public health practice. As a prelude to our next episode, we ask the question whether racism or racial discrimination, should replace ‘race’ as a social determinant of health. What do you think?We would love it if you followed us and shared your thoughts with us through direct messages on Instagram, Twitter, Facebook, or by emailing us at ThePublicHealthInsight@gmail.comIcon made by Freepik from www.flaticon.comSupport the show (https://www.patreon.com/publichealthinsight)

In the first episode of the Social Determinants of Health (SDOH) series, Avalere experts set the stage for how stakeholders are defining SDOH and the impacts of SDOH on health outcomes, specifically when addressing social risks and needs.

On this episode of the Health in Public Housing Podcast Series, NCHPH interviews Teresita Lawson, RPh, CDE to further address various factors that contribute to the social determinants of health in addition to the effects that they have on persons living with diabetes. MUSIC: Local Forecast by Kevin MacLeod https://incompetech.filmmusic.io/song/3989-local-forecast https://creativecommons.org/licenses/by/4.0/

Dear Friends & Colleagues,On Friday March 27th 2020, I launched a limited podcast series addressing how the COVID-19 pandemic is reframing American healthcare.  You can find the introductory episode here.  In this series, I am interviewing future-facing, courageous healthcare leaders and entrepreneurs,  asking two questions: (1) How is the COVID-19 pandemic immediately changing the way you are delivering healthcare?  (2) How will COVID-19 reframe American healthcare for years to come? In this interview we’ll be speaking with Dr. Shreya Kangovi about Community Health Workers.  Community Health Workers are individuals who have been hired from their community, and given training and support to provide customized, culturally sensitive, non-clinical care.  Their focus is on the social determinants of health - at the individual level, and delivered in a highly personalized and relationally oriented way.  To my mind, this workforce and approach to care is one of the most untapped opportunities we have to reframe healthcare and create transformative change.  It addresses the overwhelming impact that the Social Determinants of Health (SDOH) have on healthcare outcomes, utilization, costs and the experience of care. The issues of SDOH, chronic disease and disparities of care have been some of the fundamental problems in our healthcare system - problems the COVID-19 pandemic has exposed and exacerbated.  One of the solutions to our present moment and to a better future is the focus of today’s discussion.Dr. Kangovi and her colleagues have pioneered a rigorous, evidence-based approach to building, deploying and measuring the impact of a Community Health Worker (CHW) program.  Dr. Kangovi is the founder & executive director of the Penn Center for Community Health Workers - a national center of excellence dedicated to advancing health in low-income populations through CHW programs. She and her colleagues have spent nearly a decade creating and refining a world-class CHW model called IMPaCT™ (Individualized Management towards Patient-Centered Targets).  Now, they are offering this program to other institutions to encourage widespread deployment.In this interview, we’ll dive into the following:Six major problems in healthcare - caused and/or exacerbated by the COVID-19 pandemic - that are leading to American deaths.What Dr. Kangovi refers to as the “structural racism” embedded in our healthcare delivery system - and what can be done to reverse it.A detailed description of the Community Health Worker approach to COVID-19 contact tracing, and...  The one critical question that drives the highly effective and personalized IMPaCT™ Community Health Worker approach.The Community Health Worker model is proven to be cost effective, replicable, and complementary. However, in order to implement this model throughout the country, we need a system of care that pays for outcomes, not for procedures or transactions.  Fee-For-Service payment is the “big but” in American healthcare. This has been a common mantra that has emerged in most of the interviews I’ve conducted during this pandemic.  If we shifted to a capitated, value-based payment approach (at least with primary care), we would be able to rapidly and easily deploy effective, humanistic solutions such as Community Health Workers.  From my perspective, one of the most important lessons the COVID-19 pandemic has taught us is that Fee-For-Service payment makes both providers and patients vulnerable. It is unsustainable, and frankly harmful to the health of the American public and the American economy.  It’s also not the type of compensation model that fosters meaningful, relationship-enhancing careers for primary care providers as well as specialists. We can talk about a lot of things, but until we fix this one major impediment, we will be propagating an out-dated and misaligned approach to healthcare delivery.  My hope is that this current crisis serves as a catalyst for changing that, and addressing many of the other fundamental flaws in our healthcare system, like disparities in care.  We need courageous leaders to speak up, step up, collaborate across the various stakeholders, and to take directed actions to create a new, and more humanistic, approach to healthcare.  Until next time, be safe and be well.Zeev Neuwirth, MD 

The Opportunity Zones incentive is a new community investment tool to encourage long-term investments in low-income urban and rural communities nationwide. Nightingale is accelerating the health care industry's ability to deploy underfunded SDOH benefits by leveraging the innovative financing mechanisms of Opportunity Zones, to catalyze a new marketplace of social service providers. Joining us today is the Founder of Nightingale Partners, John Gorman, to talk about one solution that is good for society, good for patients, and good for business. Show Notes I like to say, social determinants of health are just four fancy words for poverty. We hacked a Republican billionaire tax shelter to try to improve healthcare for black and brown people in inner cities. You can never get to compliant patients who are participating in population health activities unless their basic needs get met. Breaking down silos to sign patients up for all available social services. The Community Health Worker is the linchpin of any successful social determinant intervention. Designing a management services organization to facilitate rent and utility subsidies for thousands of people. Cultural competency and the "execution risk" for new interventions. Case Study: Adult Daycare Centers in Puerto Rico They're dropping $21 million on some big slick analytics package and I was like, " What is that actually going to do for you if you can't stand up an intervention the right way?" That's like putting the greatest scope in the world on a really rusty rifle. If you give me $21 million worth of social workers, I'll change the world. John Gorman, Founder John is the Founder and former Executive Chairman of Gorman Health Group, at the time the industry's leading consulting practice which spawned almost a dozen entrepreneurial ventures in government health programs. John's work focuses on Medicare, Medicaid, and Affordable Care Act strategy, governance, and turnaround of distressed health plans. Prior to founding the firm, John served as Assistant to the Director of Health Care Financing Administration's (HCFA, now CMS) Office of Managed Care, where he provided day-to-day management and served as the external liaison for the Medicare and Medicaid managed care programs. During the 1993 debate on national health care reform, John was chief lobbyist on health care financing issues for the National Association of Community Health Centers, an organization of federally-funded primary care clinics for the medically underserved. John's career in Washington began as Press Secretary and Staff Director for U.S. Representative John Conyers, Jr. (D-MI), then Chairman of the Government Operations Committee. John serves on the Board of Directors of Henry Ford Health System's Health Alliance Plan in his birthplace of Detroit, MI, and serves as a Senior Advisor to Premier, Inc., the hospital purchasing cooperative, on Medicare Advantage and Medicaid matters. Nightingale Partners LLC  Nightingale Partners LLC is a Qualified Opportunity Zone (OZ) fund and advisory firm that identifies, collaborates and invests in market-ready health care initiatives in OZs nationwide. NP focuses on designing evidence-based, targeted, non-clinical interventions addressing Social Determinants of Health (SDOH) for Medicaid and Medicare enrollees through creative partnerships with High-Net Worth Individuals, Institutional Investors, Government Agencies and Strategic Health Plans/Providers. Resources, Links, and Related Episodes Nightingale Partners https://www.linkedin.com/company/nightingale-partners-ll https://www.nightingalepartners.org/ John Gorman https://www.linkedin.com/in/john-gorman-098b265 https://twitter.com/johngorman18?lang=en

In this podcast, Andres Gutierrez discusses approaches to integrating the Social Determinants of Health (SDOH) into technologies used in healthcare. He also shares the challenges and benefits of harnessing the data to drive better health outcomes and the community partnerships required to bring lasting change. https://archive.org/download/ep31andresgutierrez/EP%2031%20-%20Andres%20Gutierrez.mp3

This season, RadioRev is taking a new approach and diving into one specific, yet very important and diverse topic: Social Determinants of Health (SDoH). We have a lineup of 8 guests and counting, with a few surprises and special episodes along the way to cover all aspects of this complex topic. The goal of this season is to provide various viewpoints on social determinants of health with a different industry expert each week with the hope that you take away new ideas, perspectives, and are inspired to look at SDoH in a new light, from all angles. As a collective, the conversations from these episodes are meant to build upon one another to inspire innovation and motivate the healthcare industry to work together and establish partnerships to create meaningful solutions that help people live stronger, healthier lives. Please join me on this journey over the next several weeks as we talk with industry experts about how to define SDoH and as an industry, and get on the same page to have the biggest and most successful impact possible. Topics we’ll be covering this season include: why we’re talking about SDoH now how there isn’t a one-size-fits all solution innovations to address food scarcity a discussion about rural communities and SDoH and more! Join us for the kickoff episode of the season, hitting your favorite podcast platform on March 10, 2020. To be the first to hear about new episodes from RadioRev, make sure to subscribe where ever you listen to podcasts.

Welcome to the Alpha Coding Podcast series with your host, Toni Elhoms, CCS, CPC, CRC, AHIMA-Approved ICD-10-CM/PCS Trainer! Episode 4 will cover my top 5 Pro-Tips for Coding the Social Determinants of Health (SDOH). Report coding SDOH data whenever appropriate Know where to find SDOH documentation Understand who can record the SDOH documentation Understand how to capture additional coding opportunities for SDOH patients Recognize how important SDOH data is in the big picture Join us every Monday for your all-access pass to medical coding and billing Pro-Tips that help you start your week off smarter! If you would like to become a sponsor of Alpha Coding Podcast, please contact us directly for pricing: AlphaCodingExperts@gmail.com

We continue the conversation of Social Determinants of Health (SDoH) in the second part of our series. Factors such as poverty, unstable housing, environment, lifestyle, and education continue to affect the day-to-day delivery of care of patients. Accounting for these factors and capturing data on them can improve care delivery and care equity.1 In Part Two of the SDoH Series, hear from: Bill Maroon, Director of Business Development & Innovation for Resources for Human Development (RHD), a national human services non-profit with programs across the entire mental health space. Deb Adler, Senior Associate at OPEN MINDS and former Senior Vice President of Network Strategy with Optum. Mr. Maroon will provide the provider organization perspective and discuss how RHD was able to: • Achieve measurable consumer improvements in quality and health care cost savings • Address how SDoH were used as a vehicle to launch value-based reimbursement models (e.g. risk-sharing, pay-for-performance). Ms. Adler will discuss the American Medical Association’s efforts to develop CPT codes for SDoH in coordination with UnitedHealthcare, which represents a large scale movement to implement consistent collection and reporting for SDoH. Join PsychU and hear more about prospective health plan utilization of initiatives to address SDoH. This snapshot is supported by findings of a recent survey of 1,200+ payer organizations. The full report, A Population Health Manager’s Reference Guide On The U.S. Behavioral Health Financing & Delivery System, the 2nd Edition of the Trends In Behavioral Health report, is currently available on PsychU.org.1 Ms. Adler is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. 1 Blas, E., Sommerfeld, J., & Kurup, A. S. (2011). Social determinants approaches to public health: from concept to practice. Geneva, Switzerland: World Health Organization. Retrieved from https://www.who.int/sdhconference/resources/SDapproachestopublichealth_eng.pdf?ua=1. 2Otsuka America Pharmaceutical, Inc. & Lundbeck, LLC. (2019). A Population Health Manager’s Reference Guide on the US Behavioral Health Financing and Delivery System, 2nd Edition. Rockville, MD: Otsuka America Pharmaceutical, Inc. Retrieved from PsychU.org. Bill Maroon, MSW, is the Director of Business Development & Innovation for RHD. Since 2015, he has been an integral part of negotiating, developing, and implementing four Assertive Community Treatment (ACT) teams, as well as other programs focusing on SDoH for RHD. Over the last 25 years, Ms. Maroon has worked for various non-profit organizations at the cross-section of housing, homelessness, and health care. He has experience in street outreach, ACT teams, the “Housing First” model, supportive housing, case management, and integrated health care. Mr. Maroon received his Master’s Degree in Social Work from Temple University. Deb Adler, MEd, CPHQ, is a Senior Associate at OPEN MINDS. She is the Former Senior Vice President of Network Strategy for Optum, where she was responsible for behavioral health network development, contracting, and strategy for over 185,000 providers. Ms. Adler has more than 20 years of experience in executive health care roles, serving in a variety of capacities including network executive, quality management executive, and chief operating officer. Ms. Adler received her Master’s Degree in Psychology & Evaluation from Catholic University of America. She is a Certified Professional in Health Care Quality.

The next big milestone for ICD-10 is the 2018 Coordination and Maintenance Committee meeting in Baltimore. The two-day meeting covered the latest requests for diagnosis and procedure codes. Monitoring and reporting on the meeting during this edition of Talk Ten Tuesdays will be Laurie Johnson, senior healthcare consultant for Revenue Cycle Solutions, LLC and an ICD10monitor contributor. Other segments to be featured on the broadcast include: News Desk: Larry Field, DO, anchors the Talk Ten Tuesdays News Desk and reports on the newly released Fourth Universal Definition of Myocardial Infarction. Dr. Field is the treasurer of the American College of Physician Advisors. Tuesday Focus: The American Medical Association has released its 2019 code changes. Reporting on this developing story is senior healthcare consultant Deborah Grider. Mental Health Report: Catherine Harrison-Restelli, MD, medical director for hospital services at Sheppard Pratt Health System, reports on Social Determinants of Health (SdoH), especially adverse childhood events and their impact on physical and mental health. Coding Report: Gloryanne Bryant reports on steps facilities should take to strengthen their coding and compliance programs, especially in the wake of the alleged upcoding at Providence St. Joseph health system.

Few proposals from the Centers for Medicare and Medicaid Services (CMS) have generated such a plethora of opposition from concerned stakeholders as the agency’s recent proposed evaluation and management (E and M) reimbursement changes in the 2019 Medicare Physician Fee Schedule. The outrage has been intense over the plan to reimburse new patient visits at a single flat rate for codes 99202-99205 (99201 would be paid at a lower rate), while a corresponding, lower flat rate would apply to established patient visit codes 99212-99215. Code 99211 would also be paid a lower rate. The level 1 codes don’t get the flat rate, because they don’t require the presence of a physician. Making a final stand in opposition to the proposed changes during this edition of Monitor Mondays will Dr. Steven J. Meyerson, board-certified in internal medicine and geriatrics, and Holly Louie, past president of the Healthcare Business and Management Association. The broadcast rundown also will include: Monday Rounds: Ronald Hirsch, MD, vice president of R1 Physician Advisory Services, makes his Monday Rounds with another installment of his popular segment. Monday Focus: Social Determinants of Health (SdoH) are coming into sharp focus, as Tropical Gordon impacted parts of the Central Gulf Coast this week. It brought with it memories of Hurricane Harvey and its impact that is still being experienced in Houston, especially among the poor, the unemployed, and the disenfranchised – those who are predisposed to SDoH. Reporting on the compliance issues surrounding SDoH will be nationally recognized topic authority Ellen Fink-Samnick. Hot Topics: Monitor Mondays senior correspondent Nancy Beckley, president and CEO of Nancy Beckley and Associates, reports on all the latest hot topics. Risky Business: Healthcare attorney David Glaser with Fredrikson & Byron reports on another example of a potentially troublesome issue that could pose a risk to your facility. Monitor with us™

Sir Michael Marmot, past President, British Medical Association, Chair of the World Health Organization’s commission on the Social Determinants of Health (SDOH) joins us to discuss his seminal research. Released on the 70th anniversary of the founding of the UK’s National Health Service. We discuss the changing roles and targets of governments in creating better health, not simply care, and ...

To be understood, seek first to understand. It applies in life, and it applies when you're trying to gain traction with an innovative product, solution, or workflow in the Health IT market. Why? Because there are too many draws on your customers' attention. If you want them to take the time to understand you, then you'd better position yourself where they already are, or will soon be looking. In short, get to know your market. On this episode, we're talking with Dexter Braff, President of The Braff Group, one of the nation's leading health care merger and acquisition advisory firms. Dexter walks us through the analysis his team performed on the Health IT market and shares with us key insights they uncovered along the way. They studied 300-400 transactions, identified patterns of consolidation, and used their findings to re-categorize the entire Health IT market. You'll benefit from understanding the process they went through, and you'll get to take a few shortcuts via the insights he shares. What you'll learn: How to survey the Health IT market landscape and organize it into understandable categories How to use your market analysis to predict where market consolidation is likely to occur Which Health IT Market categories are experiencing the most consolidation and M&A activity. Interestingly, more than 40% of the transactions The Braff Group examined came from a single category. Predictions on which categories will move next A breakdown of the forces expected to drive the next round of consolidation Different approaches to enable "Collaborative Reimbursement" across provider disciplines (i.e. Bundled payments and other innovative reimbursement programs) Why we should be mindful of the potential value in Social Determinants of Health (SDOH) data. The differences between cutting edge and bleeding edge and the importance of timing. And if you enjoy this one, be on the lookout for Part 2 with Dexter Braff where he offers practical advice on how companies can best position themselves for future raises and acquisitions. ~ Don Lee     About Dexter Braff: Dexter W. Braff is President of The Braff Group, one of the nation's leading health care merger and acquisition advisory firms (source: Thomson Reuters). Since its founding in 1998, the firm has completed more than 300 health care deals. With 30 years of experience representing health care service companies, Dexter is recognized as the industry expert in health care M&A. He has written and contributed to feature articles that have appeared in numerous health care industry publications and has written a chapter in the Handbook of Business Valuation published by John Wiley & Sons. He is frequently interviewed on various topics regarding health care mergers and acquisitions by news outlets including Bloomberg News, CNBC, USA Today, The Huffington Post, The Palm Beach Times, and numerous health care sector journals. Additionally, the firm is the publisher of marketWATCH, a quarterly review of mergers and acquisitions activity in six industry segments: Behavioral Health Care, Health Care Information Technology, Home Health and Hospice, Pharmacy Services, Urgent Care, and Home Medical Equipment. Dexter has presented seminars, webinars, moderated discussion panels, and has been the keynote speaker on various issues regarding health care mergers and acquisitions and finance at conferences across the country including Art of the Deal, the Remington Think Tank, Health Care Capital Investors Conference, HME News Business Summit, HHFMA Financial Managers Conference, Treatment Center Investment and Valuation, Foundations: Moments of Change, Behavioral Health Care: Buying, Selling and Valuing, National Association for Home Care, National Home Infusion Association Conference, Homecare 100, Long Term Care 100, Medtrade, Urgent Care Association of America, and many more. He was recently inducted into The Home Care and Hospice Financial Managers Association Hall of Fame as “deal-maker extraordinaire.” Dexter holds an MBA from the University of Pittsburgh, a Master of Science from the University of Oregon, a Bachelors of Arts from Cornell University, and received the Vincent W. Lanfear Award for academic achievement. About The Braff Group: The Braff Group is a leading mergers and acquisitions advisory firm specializing exclusively in health care services including behavioral health care, home health care, hospice, pharmacy services (home infusion, specialty Rx, institutional Rx), urgent care, health care information technology, health care staffing, home medical equipment, and ancillary health care services. Unlike many brokers and investment sectors that work many sides of the negotiating table which can create conflicts of interest, we provide sell-side only transaction advisory services including representation, divestiture strategy, debt and equity recapitalizations, and valuation. Since the firm's inception in 1998, we have closed more than 300 transactions, more than any other mergers and acquisitions advisory firm covering these sectors. Mentioned on the podcast: Dexter mentioned a chart that shows his team's analysis of the Health IT Market categories. You can find it here under Market Data - M&A Environment for HIT. Related: Accelerating Digital Health for Social Good | Christian Seale | Startupbootcamp Miami On this episode Christian talks about sub-categories within the market that can be drawn by community and cultural lines. A very interesting supplement to Dexter Braff's analysis. Subscribe to Weekly Updates: If you like what we're doing here, then please consider signing up for our weekly newsletter. You'll get one email from me each week detailing: New podcast episodes and blog posts. Content or ideas that I've found valuable in the past week. Insider info about the show like stats, upcoming episodes and future plans that I won't put anywhere else. Plain text and straight from the heart :) No SPAM or fancy graphics and you can unsubscribe with a single click anytime. The #HCBiz Show! is produced by Glide Health IT, LLC in partnership with Netspective Media. Music by StudioEtar

People like to say things like "If you've seen one healthcare system, then you've seen one healthcare system" or "every community is different". That may be true on some level, but these are really just  excuses to keep doing things the same old way.  In fact, most communities are exactly the same when it comes to the most important issues facing the U.S. healthcare system. If you pick any random community across the country and examine their healthcare delivery system, you'll find that: Traditional healthcare delivery accounts for only 10-20% of health outcomes. Social Determinants of Health (SDOH) drive the rest. Healthcare costs are growing in an unsustainable manner There's heavy competition between the players in the community and limited collaboration Governments, companies and individuals are struggling to pay for it all On this episode, Jim Rickards MD, MBA tells us the story of how Yamhill County, Oregon is addressing these issues through their Community Care Organization (CCO). Made possible by Oregon's 1115 Medicaid Waiver, the CCO is a community governed health plan that brings competing hospitals, providers, dentists, community leaders, patients and their families to the table. The CCO, as Jim puts it, "gave the community permission to work together". And they have. Whether it be allowing patients to choose Naturopaths  as PCPs, tapping latent community resources to launch a paramedicine program, or the creative approach to engaging highschoolers through "Teen Swag Night", Yamhill County has shown that there are ways to move the needle on some of our most pressing healthcare issues. It just takes a change in perspective. This all comes from Jim's new book, Our Health Plan: Community Governed Healthcare That Works. It's very well written and accessible even if you're not an expert in healthcare delivery or the business of healthcare in general. I highly recommend it to anyone trying to drive collaboration in their community, or just generally looking for a new approach to addressing the Social Determinants of Health (SDOH). "The CCO gave the community permission to work together" -Jim Rickards MD, MBA Here's a breakdown of the topics we discuss: What is a Community Care Organization? (1:00) What was the catalyst for Medicaid reform in Oregon? What are the 3 ways to reduce healthcare spending? (12:15) What was your strategy for getting competitors to collaborate? (16:30) How is the health plan funded? (27:30) Can you give some examples of community collaboration that drove meaningful changes? (32:30) Quality Measurement: How do you (and CMS) ensure that you're doing a good job for the community and the patients? (37:30) How did you pick your clinical quality measures? (42:40) Are the providers on board with the quality measures? (44:00) Tell us how the CCO helps the doctors meet their quality measures, as opposed to just measuring them. (46:25) What is "Teen Swag Night" and how does it help you close gaps in care? (47:00) Do you think the program has been successful? (51:00) Do the providers and others stakeholders in your community think the program has been successful? (52:15) What things might a critic point to as still needing work? (53:00) This was a 5 year program and has been extended by CMS. When did things click for you? When did you start to feel like you were making an impact? (55:00) Tell us about the Teledermatology program. (57:30) Give it a listen and then give yourselves permission to work together. ~ Don Lee   About Jim Rickards MD, MBA Jim Rickards MD, MBA is the senior medical director at Moda Health in Portland, Oregon and author of Our Health Plan. He was a pioneer in developing the Coordinated Care Model for the state of Oregon as a new way to deliver healthcare services to its nearly 1.1 million Medicaid members. Previously, Dr. Rickards was the Chief Medical Officer of the Oregon Health Authority, where he provided clinical and policy leadership in managing Oregon's Medicaid population. He received his B.S. from Indiana University Bloomington, MBA from Oregon Health and Science University, M.D. from Indiana University School of Medicine, and completed residency and fellowship training in radiology in Chicago at Cook County Hospital and Rush University Hospital, respectively. Dr. Rickards currently resides in Mcminnville, Oregon. Learn more: jimrickardsmd.com Related If you're into innovation you might also like: Accelerating Digital Health for Social Good | Christian Seale | Startupbootcamp Miami Replay: Medicaid Open IT with Open Health News Bringing Direct Primary Care to Medicaid Weekly Updates If you like what we're doing here, then please consider signing up for our weekly newsletter. You'll get one email from me each week detailing: New podcast episodes and blog posts. Content or ideas that I've found valuable in the past week. Insider info about the show like stats, upcoming episodes and future plans that I won't put anywhere else. Plain text and straight from the heart :) No SPAM or fancy graphics and you can unsubscribe with a single click anytime. The #HCBiz Show! is produced by Glide Health IT, LLC in partnership with Netspective Media. Music by StudioEtar